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Abstract 
In a multicellular organism the fate of cells is regulated by the surrounding 
environment. One important example of such a regulation is the development 
of blood cells. This complex process during which all type of blood cells are 
produced from a common pluripotent precursor cell is named hematopoiesis. 
In the adult mammals hematopoiesis is restricted to the extravascular 
compartments of the hone marrow, where primitive hematopoietic cells and 
their progeny develop in intimate contiguity with hone marrow 
microenvironment. Heterogeneaus populations of stromal cells and 
components of extracellular matrix (ECM) have been identified as a part of 
this microenvironment. A crucial component of the ECM in hone marrow is 
hyaluronic acid (HA) which is instrumental for the organisation of ECM. 
Moreover HA can act as a signalling molecule regulating cellular functions. 
This work is based on the observation that in an in vitro hematopoietic 
system, the so-called Long Term Bone Marrow Culture (L TBMC), HA 
addition enhances the production of progenitor and mature cells by inducing 
the production of the crucial hematopoietic cytokine IL-6 in Bone Marrow 
Derived Macraphages (BMDM). 
To gain insight into the mechanisms of HA-regulated cytokine production, I 
established a system consisting of the progenitor cell line TF-1 and the 
hematopoietic supportive stromal cellline MS-5. HA triggers the production 
of cytokines IL-6, GM-CSF and IL-4 in MS-5 cells. I found HA regulates 
production of the IL-6 cytokine via the RAF-MEK-ERK signal transduction 
pathway. HA-induced production of IL-6 is regulated on the transcriptional 
Ievel, via NF-lCB and NF-IL-6 binding-sequences in the IL-6 promoter. 
The TF -1 progenitor cell line also induces the production of cytokines in the 
MS-5 cells. Furthermore, the induction of IL-6 by TF-1 cells is also 
regulated on the transcriptionallevel and is mediated by NF-KB and NF-IL-6 
cis-elements in the IL-6 promoter. 
Taken tagether these data explore the mechanism of regulated cytokine 
production by stromal cells and underline the importance of ECM-cell and 
cell-cell interactions in hematopoiesis. 
Hyaluronsäure induziert Zytokine in Stromazellen 
welche Hämatopoiese unterstützen 
Zusammenfassung 
In ei9em multizellulären Organismus wird das Zellschicksal durch 
Umgebungseinflüsse reguliert. Ein wichtiges Beispiel für eine solche Regulation 
ist die· Entwicklung von Blutzellen. Dieser komplexe Prozeß, bei dem alle Arten 
von Blutzellen aus einer gemeinsamen pluripotenten Vorläuferzelle produziert 
werden, wird als Hämatopoiese bezeichnet. 
In erwachsenen Säugetieren ist die Hämatopoiese auf die extravasalen 
Kompartimente des Knochenmarks beschränkt, wo einfache hämatopoietische 
Zellen und ihre Abkömmlinge sich in enger Einbindung in der Mikroumgebung 
des Knochenmarks entwickeln. Heterogene Populationen von Stromazellen und 
Komponenten der extrazellulären Matrix (ECM) sind als Bestandteile dieser 
Mikroumgebung identifiziert worden. Ein entscheidender Bestandteil der ECM 
des Knochenmarks ist Hyaluronsäure (HA), die wesentlich an der Organisation 
der ECM beteiligt ist. Darüber hinaus kann HA als Signalmolekül 
funktionieren, welches zelluläre Funktionen reguliert. 
Die hier vorliegende Arbeit basiert auf der Beobachtung, daß HA in einem in-
vitro System, der sog. Langzeit-Knochenmarkskultur (LTBMC), die Produktion 
von Vorläuferzellen und reifen Zellen erhöht, indem es die Produktion des 
entscheidenden hämatopoietischen Zytokins, IL-6, in den vom Knochenmark 
abgeleiteten Makrophagen (BMDM), induziert. 
Um Einsicht in die Mechanismen der HA-regulierten Zytokin-Produktion zu 
erhalten, habe ich ein System mit der hämatopoietischen Vorläufer-Zelllinie 
TF-1 und der supportiven Stromazelllinie MS-5 etabliert. HA löst die 
Produktion der Zytokine IL-6, GM-CSF und IL-4 in MS-5 Zellen aus. Ich fand 
heraus, daß HA die Produktion des Zytokins IL-6 über den Raf-MEK-ERK 
Signaltransduktionsweg reguliert. Die HA-induzierte Produktion von IL-6 wird 
auf transkriptioneHer Ebene über NF-KB und NF-IL-6 Bindesequenzen im IL-
6-Promotor reguliert. 
Die TF-1 Vorläufer-Zelllinie induziert ebenfalls die Produktion von Zytokinen 
in MS-5 Zellen. Weiterhin wird die Induktion von IL-6 durch TF-1 Zellen 
ebenfalls auftranskriptioneUer Ebene durch NF-KB und NF-IL-6 cis-Elemente 
im IL-6 Promotor reguliert. 
Zusammengenommen zeigen diese Daten die Mechanismen der durch 
Stromazellen regulierten Zytokin-Produktion und unterstreichen die Bedeutung 
von ECM-Zell- und Zell-Zell-Interaktionen während der Hämatopoiese. 
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1 lntroduction 
1.1 The extracellular matrix component hyaluronic acid (HA) 
The development and function of all cells in a mammalian organism depend on 
interactions with molecules in their environment. The classes of molecules in 
this environment represent growth factors, cell adhesion molecules and 
components of the extracellular matrix (ECM). In a multicellular organism the 
ECM controls homeostasis, cell growth and differentiation. The ECM is a 
complex and highly diverse structure, including many different components 
such as proteoglycans, glycosaminoglycans, fibronectin, collagen, laminin, 
hemonectin, thrombospondin etc. Glycosaminoglycans (GAGs) are negatively 
charged hexosamine containing polysaccharides. They are ubiquitously present 
in the ECM of connective tissues, in body fluids and can be also found on the 
cell surface. 
In the last years, glycosaminoglycans have been intensively studied because of 
their prominent role in tissue homeostasis andin pathological disorders. In this 
work we would like to introduce one member of the GAG family - hyaluronic 
acid (HA). 
1.1.1 Molecular properties of HA 
HA was originally isolated and described by Karl Meyer as the maJor 
glycosaminoglycan of the vitreous body of the eye and of the synovial fluid 
(Meyer and Palmer, 1934; Meyer et al., 1947). Later on, HA was also found in 
a number of other tissues such as the umbilical cord, the skin, the rooster comb 
and the cartilage. HA is the largest ECM component with a molecular mass of 
several million daltons. It is a linear polymer composed of disaccharide repeats 
that consist of N-acetylglycosamine and D-glucuronic acid (Fig.1) (Laurent, 
1989). 
1 
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Figure 1. The structure of HA disaccharides. 
~~~1 0-H---t 
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Because of its charged residues HA can adopt many water molecules and thus is 
able to expand into tissue spaces and to occupy an area of several magnitudes 
larger than expected from its size. The hydratation properties of HA are 
important for creation of an environment that maintains homeostasis and 
facilitates cell movement. 
In solution the HA molecules form three-dimensional structures, which show 
extensive intramolecular hydrogen bonding. This restricts the conformation 
flexibility of the polymer chains and induces distinct secondary (helical) and 
tertiary (coiled coil) structures (Evered and Whelan (eds), 1989). Because of 
such an organisation, HA behaves in aqueous solutions as an unusually stiff 
polymer. This rigidity is important for the space-filling role of HA and also for 
the formation of specific channels through which different water-soluble 
molecules can diffuse. 
Another important feature of HA is that it interacts with proteoglycans and 
other matrix components, which use the HA network in order to associate and 
orientate themselves. Thus, HA organises the macrostructure of the ECM and 
provides stability and elasticity to the organism (Knudson and Knudson, 1993), 
for example as a central structural unit in cartilage or as a lubricant in sinovial 
fluid. However, it was recently discovered that HA has a variety of other 
2 
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important functions. It influences cell differentiation, motility, proliferation and 
migration and thus affects cellular fate in the embryo as weil as in the adult 
organism (for review see Evered and Whelan (eds), 1989). In embryogenesis 
HA plays a crucial role as it surrounds the proliferating and migrating cells of 
developing tissues. The presence of HA from the very beginning of the 
development of the embryo (Brown and Papaioannou, 1993) underlines the 
importance of this molecule in a variety of decisive events oiigoing in 
embryogenesis. 
For example, HAinduces condensation ofmesenchymal cells, that results in the 
onset of chondrogenesis and myogenesis (Knudson, 1993). HA has also been 
shown to promote migratory and proliferative events during the maturation of 
the nervaus system (Erickson and Perris, 1993) and to take part in the brain 
development (Bignami et a/., 1993; Marret et a/., 1994). HA is the major 
glycosaminoglycan of the early cardiac ECM during the heart development. The 
strongest evidences for a function of HA in the development of the heart came 
from the observation that degradation of HA caused abnormal formation of the 
heart structure (Baldwin et a/., 1994). The general importance of HA in 
embryonie development is emphasised by the observation that abrogation of HA 
synthesis in knock out mice Ieads to the early death of the embryo. 
In the adult organism, in addition to the functions already mentioned above HA 
is specifically involved in hematopoiesis and in the function of the immune 
system (Minguell, 1993; Naor et al., 1997; Siegelman et a/., 1999). HA also 
contributes to the motile responses and migration of cells during wound repair 
(Weigel et a/., 1986; Weigel et a/., 1988; Weigel et a/., 1989). 
HA is also important in pathological processes such as inflammation and 
tumorigenesis. Increased Ievels of HA in the serum have been found in 
inflammatory rheumatic diseases such as rheumatoid arthritis, scleroderma and 
psoriatic arthritis (Engstrom-Laurent et al., 1985; Dahl et a/., 1985). The 
regulatory role of HA in inflammation was further confirmed by the 
observation that HA stimulates phagocytosis in monocytes and granulocytes and 
that HA mediates lymphocyte activation (Hakansson et a/., 1980; Ahlgren and 
Jarstrand, 1984; Bourguignon et a/., 1993; Galandrini et a/., 1994; de Grendele 
3 
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et al., 1996). lnteresting1y, HA like other GAGs have important functions in the 
regulation of the activity of the inflammatory cytokine IFN-y in vivo by direct 
binding and presentation of IFN-y molecules to the cells (Femandez-Botran et 
al., 1999). 
The importance of HA for cell migration suggests a role for HA in tumour 
invasion (Knudson 1996; Knudson et al., 1989). Indeed, some solid tumours 
contain high concentrations of HA that correlate with their invasiveness (Menzel 
and Farr, 1998; Hopwood et a/., 1974; Philipson and Schwartz, 1984). 
Interestingly, some tumour cells were shown not only to produce HA on their 
own but also to stimulate other cell types to increase HA production (Knudson 
et al., 1984; Knudson and Knudson, 1990; Asplund et a/., 1993). 
1.1.2 HA synthesis 
The regulation of HA synthesis and catabolism is crucial for its functions and is 
co-ordinately controlled in mammalian organisms. Usually, the synthesis of 
GAGs occurs intracellularly. lt involves elongation of sugar chain residues to 
core proteins followed by modifications in the Golgi apparatus and their 
transport in vesicels to the cell surface. In contrast, the synthesis of the 
enormously huge HA molecule occurs in the plasma membrane (Prehm, 1989). 
The HA synthase (HAS) synthesises HA residues at the inner surface of the 
plasma membrane and the growing HA chain is then extruded through the 
membrane directly into the extracellular space. 
The HA synthesis correlates with the stages of embryonie development, with 
tissue remodeHing and cellular multiplication processes in the adult organism 
(Teder et al., 1995). HA synthesis was also found to be significantly increased 
during inflammation and cancer (Laurent, 1989). The elevation of HA in these 
processes is regulated by growth factors or/and other mediators that can 
stimulate HA synthesis. Indeed, several factors were shown to be involved in the 
regulation of HASes activity such as TGF-~, TNF, IFN-y, PDGF, IGF-1, IL-1 
(Haubeck et al., 1995; Heidin et al., 1989; Heidin et al., 1992; Honda et a/., 
1991; Sampson et al., 1992; Ito et al., 1993). 
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1.1.3 Catabolism of HA 
HA exists as a high molecular weight polymer, but it can be degraded during 
different physiological and pathological processes. In mamrnals, three groups of 
enzymes degrade HA into its monosaccharides components, namely 
hyaluronidases (HA«ase), ~-D-glucuronidases and ~-N-acetyl-D­
hexosaminidases. Hyaluronidases are exclusively involved in the degradation of 
HA and connective tissue polysaccharides, whereas the exoglycosidases (~-D­
glucuronidase and ~-N-acetyl-D-hexosaminidase) participate in addition in the 
catabolism of other substrates. There are several groups of hyaluronidases which 
can specifically degrade HA, using different reaction mechanisms (Csoka et al., 
1997). 
The mammalian forms are endohexosaminidases that randomly reduce the size 
of the polymers through a range of oligosaccharides to finally yield 
tetrasaccharide residues. As we will discuss in the following chapters, for a 
number ofHA-mediated functions the size ofthe polymer plays a crucial role. 
The turnover of HA in the body varies in different tissues according to its 
structure and to the stage of maturity. HA is transported in the lymphatic vessels 
to lymph nodes for degradation or is catabolised locally in tissues (Fraser et al., 
1983; Fraser et a/., 1988; for review see Menzel and Farr, 1988). The lymph 
nodes extract nearly 50-90% from the peripherallymph system. HA can also be 
removed directly from the blood and the lymph circulation by endothelial cells 
of the liver sinusoids. In tissues macrophages, chondrocytes, fibroblasts and 
epidermal cells take part in HA degradation. The catabolism of HA is mediated 
via receptor-mediated up-take. Two of such receptors have been described: one 
is CD44, which plays this role in fibroblasts and alveolar macrophages (Culty et 
al., 1992; Culty et a/., 1994; Hua et al., 1993) Another one was identified on 
liver endothelial cells LEC (Yannarielo- Brown et a/., 1992). In addition non-
specific endocytosis or/and binding to low affinity receptor can also take part in 
HA uptake. 
5 
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1.1.4 HA-binding proteins 
HA -binding proteins can be separated in two groups according to the structure 
of their HA-binding region. In both cases, the respective proteins have defined 
HA-binding motifs which are characterised by two basic amino acids flanking a 
region ofseven amino acids B(X7)B, among which one at least is basic (Yang et 
a/., 1994). The first group of HA-binding proteins contain only such motifs. 
These proteins can bind HA under reducing as weil as under non-reducing 
conditions. The other group ofHA-binding proteinsform in addition a common 
protein domain (link module) firstly detected in the link protein, a protein of 
the ECM that "links" HA to other ECM components. This module is 
characterised by cystein residues (in apart of HA-binding domain), which form 
disulphide bonds and establish a defined tertiary structure in the molecule 
(Goetinck et al., 1987). The functional importance of this module was 
demonstrated by the fact that HA -binding is abrogated under reducing 
conditions (Toole, 1990). 
Some of the HA binding proteins like the cartilage link protein, versican, 
aggrecan, hyaladherins bind HA within the ECM. Others are specific cell-
surface HA-binding receptors. 
1.1.5 HA-receptors 
For many of the physiological functions of HA such as cell adhesion, growth 
and migration its binding to receptors is required (for review see Sherman et 
a/., 1994). The HA -receptor association is significantly elevated in situations 
when rapid tissue tumover and remodelling occur (Csoka et a/, 1997). HA 
interactions with cell receptors also contribute to pathological processes such as 
wound healing and tumorigenesis (Laurent, 1989). Two such receptors namely 
CD44 and LIVE-I have been identified to date. The previous description of 
RHAMM (receptor for hyaluronate mediated motility) and ICAM-1 
(intercellular cell adhesion molecule-1) as cell-surface HA-receptors (Turley et 
a/., 1991; McCourt et a/., 1994) tumed outtobe based on artefacts (Hofmann 
et a/., 1998; McCourt and Gustafson, 1997). 
6 
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1.1.5.1 CD44 protein family 
CD44 was originally discovered by means of antiborlies as a protein on 
leukocytes. Now we know that CD44 comprises a family of transmembrane cell 
surface glycoproteins type I. Members of the CD44 protein family play roles in 
physiological and pathological processes such as limb development, 
hematopoiesis, lymphocyte homing, in immune responses and cancer ( for 
review see Lesley et a/., 1993a; Naor et a/., 1997). 
Proteins of the CD44 family are widely distributed on various cells, including 
keratinocytes, hematopoietic cells and many others. However, the pattem of 
CD44 expression in the body was shown to be specific for certain cell types and 
for differentiation stages. 
The standardform of CD44 (CD44s) consists of a stretch of 248 amino acid in 
the extracellular part, a stretch of 23 amino acid comprising the transmembrane 
part and of a stretch of 70 amino acid establishing the intracellular part. The 
variety of CD44 isoforms is created by alternative splicing of variant exons 
sequences that are all excised in the CD44s isoform (Stamenkovic et a/., 1991; 
Screaton et a/., 1992). The difference between CD44s and the higher molecular 
weight variant forms (CD44v) consists of additional peptide sequences inserted 
into the membrane-proximal extracellular part of the CD44s molecule. Different 
splice variants of CD44 are believed to have distinct physiological functions. 
For example, CD44 variants containing the variant exon 6 (v6) were shown to 
confer the metastatic potential to non- metastatic pancreatic carcinoma cells 
upon transfection (Herrlich et al., 1993). Exon v6 containing variants are 
expressed on BIT lymphocytes and on macrophages upon antigenic stimulation. 
CD44 variants containing v7 exon sequences are involved in chronic 
inflammatory diseases (Wittig et a/., 1997). A v3 containing variant is crucial 
for limb development. In this case the function of the CD44 variant appeared to 
be the presentation of growth factors to target cells (Bennett et al., 1995; 
Sherman et a/., 1998). 
Many if not all functions of CD44 require binding to a Iigand. CD44 can bind 
several molecules such as fibronectin (Jalkanen and Jalkanen, 1992; Toyama-
7 
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Sorimachi et al., 1995) collagen, laminin {Turley et a/., 1984) the chondroitin 
sulfate modified form of the invariant chain (Naujokas et a/., 1993), 
osteopontin (Weber et al., 1996) and some growth factors {Tanaka et a/., 1993; 
Bennett et a/., 1995; Van der Voort et a/., 1999). The best characterised Iigand 
of CD44 is HA (Aruffo et al., 1990; Miyake et a/., 1990). 
The evidence that CD44 is a cell surface receptor for HA came from the 
observation that purified CD44 can bind HA in vitro and specific antibodies 
against CD44 block HA-binding to the cell surface. In addition, introduction of 
CD44 into cells that do not bind HA confer the HA binding ability (for review 
see Lesly et al., 1993a). 
CD44 has two HA-binding motifs in its extracellular domain similar to those of 
other HA-binding proteins (see above) (Peach et al., 1993). The significance of 
these two motifs with respect to HA-binding was confirmed by site -directed 
mutagenesis. One additional motif for HA-binding was found in the cytoplasmic 
tail of CD44. lt is functional in vitro, although its functional role in vivo is still 
not clear. In addition to these binding motifs, a secondary loop structure forms 
the link domain characteristic for HA binding (see above) in the N-terminus of 
CD44. The minimal size of HA molecule CD44 can interact with is six sugar 
disaccharides, but higher affinity is observed for Ionger HA molecules 
(Underhill et a/., 1983). 
HA-binding of CD44 can be modulated 
Many cells do not bind HA, although they express high Ievels of CD44, 
suggesting that additional activating events are necessary. Indeed, some cells can 
be "activated" to bind HA by various stimuli including certain CD44 antibodies. 
For example, the CD44 specific monoclonal antibodies (mAbs) IRA WB14 as 
well as antigenic stimulation can induce non HA-binding T-cells to bind HA 
(Lesley and Hyman, 1992). Cytokines regulate CD44 dependent HA binding of 
cells of the immune system. E.g. the cytokine TNF-a increases HA-binding of 
monocytes, whereas IL-4 and IL-13 decrease it (Levesque et al., 1999; 
Levesque and Haynes, 1997). IL-5 stimulates CD44 dependent HA binding in 
B-cells (Murakami et al., 1990). The bacterial component LPS 
8 
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(lipopolysaccharide) was shown to stimulate CD44 mediated HA-binding in 
peripherial blood monocytes (Levesque and Reines, 1997). TP A treatment can 
also activate CD44 mediated HA-binding (Liao et al., 1993; Sionov and Naor, 
1998). 
Cross-linking or dustering of CD44 may influence its HA binding. This can be 
concluded from the observation that only multivalently binding anti-CD44 
antibodies enhance HA-binding ability to CD44 receptors (Lesley et al., 1993b; 
Sleeman et a/., 1996; Liu et a/., 1997). Interestingly, in some experiments the 
cytoplasmic portion of CD44 also influences HA binding, since the truncation 
of this part results in the reduction of HA binding {Thomas et a/., 1992; Lesley 
et al., 1992; Liao et al., 1993; He et a/., 1992). However in other experimental 
systems it bad no influence. 
CD44 interacts specifically with cytoskeleton elements such as ankyrin 
(Bourguignon et al., 1992) and actin (Lacy et al., 1987) via the "linker 
proteins" ezrin, radixin, moesin and merlin (Algrain et a/., 1993; Tsukita et a/., 
1994; Hirao et a/., 1996). However the significance of such interactions for HA 
binding is still a matter of discussion. Prevention of ankyrin binding to CD44 or 
disruption of actin polymerisation and actinomyosin contractions abrogates 
CD44-mediated HA-binding in some systems (Lokeshwar et a/., 1994; Galluzzo 
et a/., 1995). In contrast, there are data indicating that disruption of the 
cytoskeleton by itself does not affect CD44 mediated HA binding (Murakami et 
a/., 1994). 
The HA-binding ability of CD44 proteins is dependent on the type of isoform 
expressed and on the post-translation modifications. For example, the presence 
of splice variants on human T-cells Ieads to an increase in HA-binding as 
compared to cells expressing only the standard form. Moreover, activated 
human T -cells transiently express v6 and v9 CD44 variants, and their expression 
is important for adhesion of these cells to HA (Galluzo et a/., 1995). Some 
CD44 isoforms also play critical roles in mediating HA dependent adhesion in 
dendritic cells (Haegel-Kronenberger et al., 1998). 
CD44 isoforms differ in the repertoire of ligands they interact with. E.g. 
inclusion of peptide sequences encoded by the v6 and the v7 exons extends the 
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repertoire of GAGs, to which CD44 can bind, to chondroitin sulfate, heparin 
and heparin sulfate as weil if CD44 is solubilised or it is expressed on the cell 
surface (Sleeman et al., 1997). 
The importance of CD44 posttranscriptional modifications for HA binding was 
demonstrated by experimental modifying of CD44. CD44 has potential 
glycosylation and phosphorylation sites and can also undergo glycanation. 
Sulfatation and addition of chondroitin sulfate are required for HA-binding by 
CD44 in some cells (Esford et a/., 1998). Keratinsulfate modification of CD44 
has an inhibitory effect on its HA binding (Takahashi et a/., 1996). 
The glycosylation status of CD44 is important for its HA-binding ability 
(Katoh et a/., 1995; Bartolazzi et al., 1994; Skelton et a/., 1998). Different 
pattern of glycosylation can regulate HA-binding in both a positive and a 
negative manner. Whereas the inhibition of N-linked glycosylation of CD44 
does not influence HA-binding in colon carcinoma cells, the inhibition of 0-
glycosylation can significantly enhance it (Dasgupta et al., 1996). In activated 
B-lymphocytes, abrogation of N-glycosylation Ieads to increased HA-binding 
(Hathcock et a/., 1993). 
However, in hematopoietic progenitor cells and in CD44v4-v7 transfected 
pancreatic tumour cells the contrary result was observed. When N-glycosylation 
was reduced HA-binding was decreased (Sleeman et a/., 1996; Moll et a/., 
1998). The importance of phosphorylation of the CD44 cytoplasmic tail for 
HA-binding in a murine systemwas shown by using CD44 mutants defective in 
phosphorylation. The abrogation of phosphorylation of the serine residues 325, 
327 led to the reduction of HA-binding (Pure et a/., 1995). However, human 
cells transfected with such defective CD44 mutants were still able to bind HA 
(Uff et a/., 1995). 
Taken together, different factors such as changes in glycosylation, distribution 
of CD44 on cell surface and modification of the cytoplasmic domain of CD44 
contribute to the regulation of CD44 mediated HA-binding. 
10 
lntroduction --------------------------------------------~ 
1.1.5.2 LIVE-1 
LIVE-I (Lymphatic vessel endothelial HA receptor I) seems to be the major 
HA receptor on lymph vessel endothelia (Banerji et al., I999). lt was shown to 
bind both immobilised and soluble HA. This receptor, similarly to CD44, is a 
member ofthe link protein superfamily. LIVE-I consists of322 aminoacids and 
shows the features of an integral membrane protein type I. LIVE-I has a 
hydrophobic domain of 2I2 amino acids with seven cystein residues, a 
serine/threonin-rich region and two motifs for N-linked glycosylation in the 
extracellular domain. LIVE-I has 4I% of homology with CD44. The region of 
the highest homology with CD44 is located in the area of the link domain. 
It is speculated that LIVE-1 functions on the surface of endothelial cells as an 
endocytic receptor like CD44 on macrophages and might be as weil involved in 
the migration of immune cells. 
1.1.6 HA as a signalling molecule 
Through its interactions with cellular receptors HA can act as a signaHing 
molecule in various systems. For example, HAinduces tyrosine phosphorylation 
of several proteins in bovine aortic endothelial cells (Slevin et al., I998), 
increases tyrosine phosphorylation of two proteins (m.w. I24 kDa and 60 kDa) 
in NIH 3T3 cells (Moon et al., I998) and triggers Ca2+ -dependent signal 
transduction cascade in T -lymphocytes followed by cytoskeleton rearrangement 
(Bourguignon et al., I993). HA mediated-activation of Mitogen-Activated 
Protein Kinases (MAPKs) was also observed in several cell types (Slevin et al .• 
I998; Khaldoyanidi et al., 1999). 
HA-induced signal cascades result in regulation of expression of genes and 
thereby regulate cellular fate andlor tissue morphogenesis. One consequence of 
HA signalling is the induction of proliferation observed in the aortic endothelial 
cells andin NIH3T3 cells similar to the action of growth factors (Moon et al., 
1998). Interestingly, in primary fibroblasts HA regulates proliferation by 
increasing tubulin expression, which, in turn, drives cells through the cell cycle 
and thus promotes cell division (Greco et al., I998). 
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An important examp1e of the ro1e of HA in morphogenesis is its regulation of 
neo-vascu1arisation. Interestingly, the size of HA is crucial for this process. For 
example, neo-vascularisation during wound healing is inhibited by high-
molecular weight HA, but is induced by shorter HA products (Lees et al., 
1995). Also low molecular weight products of HA degradation, but not native 
high molecular weight HA, are able to induce angiogenesis in vivo (Deed et al., 
1997). In agreement with this observation, HA derived oligosaccharides (o-HA) 
were reported to modulate the invasive properties of bovine microvascular 
endothelial cells and synergise specifically with VEGF in the induction of 
angiogenesis (Montesano et al., 1996). Another role of low molecular weight 
HA in tissue morphogenesis is the induction of vascular tube formation by brain 
endothelial cells (Rahmanian et al., 1997). 
Most importantly, HA can trigger signals stimulating and regulating the 
expression of a number of genes crucial for the immune response and function 
of hematopoietic system. In both systems HA can stimulate the expression of 
chemokines and cytokines in a variety of cell types such as macrophages, 
monocytes, T -cells, dendritic cells (Hiro et al., 1986; Noble et al., 1993; 
Galandrini et a/., 1994; Haegel-Kronenberger et a/., 1998; McKee et al., 1996). 
E.g. rabbit peritoneal macrophages and human peripheral monocytes as weil as 
murine macrophages and dendritic cells produce IL-1 ß upon HA stimulation 
(Hiro et a/., 1986). The induction of IL-1 ß cytokine might also explain the role 
of HA in pathological and physiological processes in connective tissues. In the 
inflammatory response HA induces in addition other types of inflammatory 
molecules. E.g. in dendritic cells HA triggers the expression of IL-8, IL-1 0 and 
IL-12 cytokines that then regulate the maturation and function of immune cells 
(Haegel-Kronenberger et al., 1998). 
HA fragments can induce the metalloelastase (MME) production in mouse 
alveolar macrophages. MME is implicated in different lung disorders. Therefore 
HA fragments, which usually accumulate at sites of lung inflammation, may 
trigger the expression of MME by macrophages resulting in lung inflammation 
(Horton et al., 1999). Several other genes of the inflammatory response such as 
MIP-1 a, the cytokine responsive gene-2 and the monocyte chemoattractant 
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protein-1 were identified to be induced upon treatment of macrophages with 
HA-fragments (McKee et al., 1996). In human alveolar macrophages from 
patients suffering from idiopathic pulmonary fibrosis IL=8 mRNA was also 
significantly increased upon HA-fragments treatment (McKee et al., 1996). In 
alveolar macrophages HA also induces the expression of inducible nitric oxide 
synthase (INOS), another molecule involved in the inflamrnatory response. HA 
fragments can induce INOS expression on their own, but the expression of the 
INOS gene is significantly increased when HA synergizes with INF-y (McKee et 
al., 1997). 
In hematopoiesis HA has an enhancing effect on the production of blood cells in 
vitro, that is due to the increased production of IL-6, one of the crucial 
hematopoietic cytokine, by hone marrow derived macrophages (BMDM) 
(Khaldoyanidi et al., 1999). Dendritic cells respond to HA also by upregulation 
of cytokines relevant for hematopoiesis such as IL-6 and GM-CSF (Haegel= 
Kronenherger et al., 1998). 
1.2 Hematopoiesis 
Throughout their lifespan all mamrnals continuously produce different types of 
blood cells such as monocytes/macrophages, red cells, platelets, T and B 
lymphocytes and neutrophils in a process called hematopoiesis. 
These cells all originate from comrnon pluripotent hematopoietic stem cells 
(HSCs). The HSCs are the only cells that are able to fully reconstitute the 
hematopoietic system of animals in which all hematopoietic cells have been 
killed upon irradiation. In addition to their differentiation capacity, HSCs are 
capable of self -renewal. 
The HSCs first differentiate into progenitor cells, which are committed to the 
various hematopoietic lineages. Therefore, in a hierarchical order, the HSCs 
initiate the production of more and more specialised cells (Fig.2) (Metcalf, 
1989). The final mature cells entering the blood are fully differentiated. The 
majority of mature blood cells are short-lived and incapable of further division. 
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Rasma oel T-all 
Figure 2. The hierarchy of the hematopoietic system. 
1.2.1 Embryonie development of hematopietic system 
The pluripotent HSCs do not develop in the embryo from the very beginning. 
Firstly, a primitive hematopoitic system is established in the embryo composed 
of primitive hematopoetic precursors for the erythro-myeloid, granulocyte-
macrophage and lymphoid lineages. The definitive (adult -type) HSCs, capable 
of full multilineage repopulation are detected in the embryo only at later stages 
(Dzierzak et al., 1998). 
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The hematopoietic system develops during embryogenesis in several tissues such 
as the yolk sac, the aorta-gonad-mesonephros (AGM), the paraaortic 
splanchnopleura (PAS), the liver, the spieen and the thymus. The earliest 
hematopoietic activities are observed in the yolk sac andin the intraembryonie 
PAS/ AGM region. These tissues develop from the mesodermal germ layer cells 
formed in the gastrulating embryo. The molecular mechanism of hematopoietic 
specification within the mesoderm involves the action of various factors of the 
TGF-ß superfamily and the FGF family (Smith and Albano, 1993; Dale et al., 
1992; Mead et al., 1996; Turpen et al., 1997). In particular BMP-4 (bone 
morphogenesis protein), a member ofthe TGF-ß family, and its receptor BMP-
2/4 play a crucial role in this early transition step. This was convincingly shown 
in BMP-4 knock out embryos the majority of which die around gastrulation 
with little or no mesoderm differentiation and the surviving embryos have 
profound defects in the yolk sac mesoderm (Winnier et al., 1995). Further 
support for a decisive role of BMP-4 in hematopoiesisis originates from the 
observation that BMP-4 can induce hematopoietic differentiation of pluripotent 
embryonie stem cells (Johansson and Willes, 1995). 
Transcription factors have also been identified that are crucial for the 
development of the embryonie hematopoietic system. The transcription factor 
Tal-1/SCL (T-cellleukaemia oncoproteinl stem cellleukaemia) is thought tobe 
the "master" gene inducing embryonie hematopoiesis and formation of HSCs. 
Tal-1/SCL-/- mice do not establish embryonie erythropoiesis within the yolk sac 
and develop no myeloid progenitors (Shivdasani et al., 1995a). In addition, Tal-
1/SCL-/- mice are also unable to generate definitive HSCs (Porcher et al., 
1996). 
The PAS/ AGM region is the primary tissue developing definitive HSCs, which 
colonise later the yolk sac. However, this does not exclude further colonisation 
of the PAS/ AGM region by the yolk sac cells (Fig.3). The yolk sac and the 
intraembryonie PAS/ AGM region represent two "pre-liver" stage tissues for 
hematopoiesis. Later, at embryonie day 9 to 11, the hematopoietic progenitors 
from these tissues inoculate the liver, which is the major hematopoietic tissue 
during the fetal stage. Fetal liver HSCs undergo daily self-renewing divisions 
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and are mobilised around embryonie day 15 to colonise the hone marrow and 
the spieen (Fig.3) (Morrison et al., 1995). 
Figure 3. Sequence of hematopoietic colonisation events in the 
deve/oping mouse embryo. Bold black arrows represent general colonisation 
events; b/ack arrows represent additional colonisation events. 
Shortly before birth, in the last stages of embryogenesis, and during the adult 
life the hone marrow becomes the major site ofhematopoiesis. 
1.2.2 Hematopoiesis in adult mammals. 
The processes of self-renewal and differentiation of pluripotent stem cells are 
maintained almost throughout the adult life span, but seem to cease at high age. 
The reduction of the proliferative capacity could be caused by a shorting of the 
telomeres in pluripotent stem cell upon more and more divisions (Vaziri et al., 
1994 ). Compatible with a function of telomers in determining the proliferation 
potential of stem cells is also the finding that self-renewing mouse 
hematopoietic cells, unlike non-self-renewing cells, express telomerase, an 
enzyme that reconstitutes telomere ends (Morrison et al., 1996). 
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The major steps of differentiation of HSCs take place in special sites of the hone 
marrow. Stern cells can circulate in the blood and can re-enter the marrow and 
re-establish hematopoiesis in the marrow cords. Thereby retention and 
migration of stem cells and progenitors within hone marrow are important 
features of hematopoiesis. 
Primitive hematopoietic precursors express a variety of cell adhesion molecules 
(CAMs) implicated in the regulation of retention and migration such as the 
integrin VLA-4 (for very late antigen), the member of sialomycin family CD34, 
the immunoglobulins CD31, CD50 and the ligands for selectin (Simmons et a/., 
1997). In particular, the interaction between the integrin VLA-4 expressed on 
HSCs and VCAM-1 expressed in the hone marrow stroma is an important key in 
the HSC retention and migration (Miyake et a/., 1991). The importance of the 
VLA -4 integrin molecule for retention is confirmed by the fact that antiborlies 
directed against this integrin can efficiently mobilise hematopoietic progenitors 
(Yang et a/., 1995; Hirsch et al., 1996). 
Immature hematopoietic progenitors receive from the hone marrow 
microenvironment a number of stimuli for further differentiation which include 
membrane- bound, soluble or ECM- associated cytokines, ECM components and 
adhesion molecules. Under the influence of these stimuli the early hematopoietic 
progenitors switch their transcriptional programs, which then determine the 
subsequent fate of the cells (Hu et a/., 1997). Several lineage-restricted 
transcription factors have already been identified as necessary for the 
hematopoietic development of particular lineages (Shivdasani and Orkin, 1996). 
For example GATA-2 and c-Myb are implicated in the maintenance and the 
expansion of most early progenitors {Tsai et a/., 1994; Mucenski et al., 1991). 
The transcription factor giving rise to erythroid differentiation is GATA-1 {Tsai 
et a/., 1989; Evans and Felsenfeld, 1989). 
The transcription factors C/EBPß (also called NF-IL-6) and PU.l were shown 
to regulate a large number of myeloid specific genes (Scott et a/., 1994; Zhang 
et a/., 1994). Ikaros, Pu-l, Pax-5 and E2A seem tobe responsible forT and B 
lymphoid lineage differentiation (Cross and Enver, et a/., 1997; Georgopoulos 
et al., 1994; Urbanek et a/., 1994; Zhuang et a/., 1994). NF-E2 was reported to 
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be specific for the megakaryocytic development (Shivdasani et al., 1995b). The 
transcription factor NF-KB plays an important role in B cells maturation 
(Franzoso et al., 1997). 
1.2.3 The structure of bone marrow 
Although in the adult organism hematopoietic precursors can be found in a 
number of tissues, the hone marrow is the only tissue in which myelopoiesis, 
lymphopoiesis and erythropoiesis occur simultaneously (Rosse, 1976). These 
processes take place in the extravasewar space between the hone marrow 
sinuses. As pictured in Fig. 4, those sinuses are organised by a sinusoidal 
network from the branches of artherias re-entering the marrow cavity. These 
sinuses collect into a large central sinus from which the blood enters the 
systemic venous circulation through emissary veins (De Bruyn, 1970). 
Figure 4. Cross-section of a long bone showing the medullary cavity 
and the marrow circulation. Redrawn from Dorshkind. 
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The development of hematopoietic progenitors strongly depends upon their 
interaction with the marrow environment (Verfaillie et al., 1994) comprising 
cellular and non-cellular components. The cellular environment in the hone 
marrow hematopoietic spaces consists of odent stromal cells such as endothelial 
cells, reticular cells, osteoblasts and adipocytes with addition of macrophages 
and lymphocytes. These stromal cells produce components of the ECM 
including proteoglycans, glycosaminoglycans, laminin, collagen, tenescin, 
fibronectin (Gallagher et al., 1983; Wight et al., 1986). The ECM tagether with 
growth factors and other molecules form the non-cellular environment for 
progenitor cells within the hone marrow. 
1.2.4 Role of the stromal cells in hematopoiesis 
The contribution of stromal cells to the regulation of hematopoiesis includes 
cell-cell interactions, cell-matrix interactions and the production of different 
soluble factors. 
In situ sturlies of the hone marrow reveal that hematopoietic cells can be found 
in close association with stromal cells. Moreover, the Ievel of this association 
depends on the maturation stage of hematopoietic progenitors (Mauch et al., 
1980; Dorshkind and Phillips, 1982; Coulombel et al., 1983). In an in vitro 
hematopoietic system called long term hone marrow culture (L TBMC) the stem 
cells and the earliest precursors bind tightly to the stromal cell layer, whereas 
more mature cells can be found in the non-adherent cell fraction of L TBMC 
(Dexter et al., 1977; Witte et al., 1987; Harrison et al., 1987). In accordance 
with this notion, the population of CD34+ cells containing predominantly 
immature precursor cells have greater affinity for stromal cells than the 
unselected pool of hematopoietic cells (Liesveld et al., 1989; Verfaillie et al., 
1990; Andrews et al., 1990; Gunji et al., 1992). Furthermore, human blast-
colony forming cells can be separated from more mature colony forming 
progenitors by using their enhanced ability to adhere to stromal cells (Gordon et 
al., 1985 Gordon et al., 1987). 
Formation of blood cells is highly dependent on those complex stromal cells -
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hematopoietic cells interactions. For example, the number of cells able to form 
colonies of differentiated cells in methylcellulose is significantly decreased in 
L TBMCs in which progenitors were separated from stromal cells by a 
membrane as compared to control cultures (Bentley, 1981). The same is also 
true for some stromal cell lines, which can be generated from the adherent layer 
of LTBMC. E.g. more colony forming hematopoietic precursors were obtained 
after co-culture of hematopoietic cells on preadipocyte stromal cell lines as 
compared to control (Kodama et al., 1982; Kodama et al., 1986). 
The cross-talk between hematopoietic cells and stromal cells is mediated by 
specific receptor-ligand interactions. The previously mentioned interaction 
between the integrin VLA-4 on hematopoietic cells with its Iigand VCAM-1 on 
the stromal cells is crucial for the development of cells of the murine B-lineage 
and human CD34+ early precursors (Simmons et al., 1992). a-VLA-4 
antibodies which abrogate binding of CD34+ cells to the stromal layer were 
reported to abolish lymphopoiesis and delay myelopoiesis in LTBMC (Miyake 
et a/., 1991). 
The cell adhesion molecule CD44 is expressed on both hematopoietic 
progenitors and stromal cells and was shown to be involved in hematopoiesis 
(Miyake et a/., 1990; Rossbach et a/., 1996; Moll et a/., 1998), although the 
Iigand for CD44 in a number of interactions between hematopoietic and stromal 
cells is not yet identified. Anti-CD44 mAbs inhibit hematopoiesis in both 
lymphoid and myeloid cultures most likely by abrogation of the attachment of 
progenitors to stromal cells. In support of this assumption, the same anti-CD44 
mAbs or the CD44 Iigand HA could prevent interaction between B-eeil 
hybridoma and stromal cells (Miyake et a/., 1990). Rosette formation of 
erythroid progenitors, an indication of their interaction with stromal cells, seems 
also to be dependent on CD44. However, this effect is not mediated by HA 
binding (Sugimoto et al., 1994). 
The adhesion of hematopoietic cells to stromal cells can also be mediated and 
modulated by cytokines. E.g. mast cells can adhere to stromal cells via the c-kit 
receptor through binding to the cytokine "stem cell factor" (SCF) (Fujita et a/., 
1989; Boswell et al., 1990; Tan et a/., 1990), which is located on stromal cells 
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(Anderson et al., 1990; Toksoz et al., 1992). Consequently mAbs abrogating 
the interaction between SCF and its receptor c-kit strongly suppress 
myelopoiesis in LTBMC (Ogawa et al., 1991; Kodama et al., 1992). CD44 
mediated adhesion of human hematopoietic CD34+ progenitors is enhanced by 
cytokines such as GM-CSF, IL-3 and SCF (Legras et al., 1997; Levesque et al., 
1995). Moreover, the cytokines IL-3, IL-6, IL-11 and SCF were shown to 
directly modulate the expression of cell adhesion molecules on hematopoietic 
progenitors (Becker et al., 1999) . 
1.2.5 The role of the ECM in hematopoiesis 
The ECM, which is produced by stromal cells, also contributes to the 
differentiation and the proliferation of progenitor cells (Dorshkind., 1990; 
Klein, 1995; Whetton and Spooncer, 1998). The different ECM molecules can 
interact with each other and thereby provide a network which embeds the 
stromal cells and the hematopoietic precursors (Long, 1992). The hematopoietic 
cells can attach to the ECM and some ECM components are preferentially 
bound by cells of particular lineages (Del Rosso et al., 1981; Giancotti et al., 
1986; Campbell et al., 1987; Campbell et al., 1988; Weinstein et al., 1989; 
Campbellet al., 1990). 
Moreover, the components of the ECM can also bind to cytokines, growth 
factors and other molecules critical for hematopoiesis and compartmentalise 
them thereby creating niches for differentiation of hemopoietic progenitor cells. 
For example, 0-sulfated heparin sulphate proteoglycans can bind cytokines IL-3 
and MIP-1 a and proteins important for hematopoiesis such a thrombospondin 
(Gupta et al., 1998). GM-CSF can be bound by bone marrow GAGs including 
HA and chondroitin sulfate and presented to hematopoietic progenitors cells 
(Gordon et al., 1987). HA as well as some other GAGs can compartmentalise 
IFN-'Y (Femandez-Botran et al., 1999). GAGs including heparan sulfate, 
chondroitin sulfate, dermatan sulfate and HA can regulate the activity of several 
cytokines and growth factors including IL-6, C-Mplligand, TGF-ß and platelet 
factor 4 (Han et al., 1996). 
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Thus, a main contribution of the ECM in hematopoiesis might be the binding of 
cytokines which are thereby regulated in their activity, which in turn is 
important for their presentation to target cells. 
1.2.6 HA in hematopoiesis. 
A crucial component of the ECM in mammalian bone marrow is HA. It is 
instrumental for the organisation of the ECM and regulates in addition the 
metabolism of cell surface glycoproteins, extracellular proteins and its own 
synthesis. 
HA is required for the adhesion of progenitor cells directly to the stromal ECM 
and to the stromal cells (Morimoto et al., 1994; Smadja-Joffe et al., 1996; 
Wilson, 1997; Mollet al., 1998). HA can in addition upregulate the expression 
of several adhesion molecules on the surface of hematopoietic cells (Oertly et 
a/., 1998). 
HA is involved in the regulation of differentiation and proliferation of certain 
lineages in the hematopoietic system. E.g. HA can inhibit the differentiation of 
lymphocytes into lymphoblastoid cells and this effect is dependent on the 
concentration and the size of HA. HA can enhance megakaryocytopoiesis by 
regulating the activity of several growth factors (Han et a/., 1996). It stimulates 
increased proliferation of CD34+ progenitors and their differentiation into 
mature eosinophils via its binding to the CD44 receptor (Hamann et a/., 1995). 
As we described in chapter 1 HA can stimulate the production of several 
cytokines crucial for the hematopoietic system. 
1.2. 7 Cytokines 
Cytokines are produced by cells to influence the growth and the differentiation 
of the same or of neighbouring cells by interacting with their specific receptors. 
Their importance for hematopoiesisis is underlined by the fact that disregulation 
of cytokine production Ieads to a variety of hematological disorders such as 
myeloproliferative syndroms, myelodisplasias and leukemias characterised by an 
22 
Introduction --------------------------------------------~ 
uncontrolled proliferation or/and an abrogation of differentiation of immature 
hematopoietic cells (for review see Beutler, Lichtman, Coller, Kipps (eds), 
1995) 
In most instances the development of certain hematopoietic lineages is 
controlled by a distinct combination of those factors. E.g. growth and 
differentiation of the myeloid lineage are stimulated mainly by the cytokines: 
GM-CSF, G-CSF, M-CSF and IL-6 and the differentiation of the lymphoid 
lineage is predominantly controlled by IL-7, IL-4 (Dorshkind, 1990). 
Some factors can also provide a negative effect on the proliferation of 
progenitor cells, thereby preventing proliferative disoders. One example is 
TGF-ß which is produced by the hone marrow cells and shows an inhibitory 
effect on both the lymphoid and the myeloid lineages. (Ohta et al., 1987; 
Lenfant et al., 1989; Dubois et al., 1990). IL-4, in addition to its stimulatory 
function (see above), can also inhibit development of both lymphoid and 
myeloid lineages directly or can induce authentic hematopoietic inhibitors 
(Peschel et al., 1987; Jansen et al., 1989; Dorshkind, 1990). 
The stromal cells of L TBMC produce several cytokines. Different 
subpopulations of hone marrow stromal cells produce distinct sets of cytokines 
(for review see Deryugina and Muller-Sieburg, 1993). This fact explains why 
certain stromal cells can support differentiation and proliferation of different 
types of progenitor cells. 
The cytokine production can be regulated by several exogenaus stimuli, 
including cytokines themselves, growth factors, bacterial LPS and ECM 
components such as HA (Tanigushi, 1988). Of particular interest is the fact that 
HA can induce the production of one of the most crucial cytokines in the 
hemapoietic system namely IL-6 (Haegel-Kronenberger et al., 1998; 
Khaldoyanidi et al., 1999). 
1.2. 7.1 Interleukine-6 ( IL-6) 
The murine IL-6 gene is located on chromosome 5 (Mock et al., 1989), the 
human IL-6 gene has been mapped to chromosome 7 (Sehgal et al., 1986). Both 
the human and the mouse genes consist of five exons. Human IL-6 shares 65% 
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homology with the mouse one. Thus, human IL-6 can substitute its mouse 
homolog (Yasukawa et al., 1987; Tanabe et al., 1988; Zilberstein et al., 1986). 
The murine protein consists of 211 amino acids (Simpson et al., 1988). 
Depending on the different posttranscriptional modifications present in the IL-6 
molecule, both mouse and human IL-6 show heterogenicity with respect to their 
molecular weight (between 21 and 29 kD) (May et al., 1988a; May et al., 
1988b ). IL-6 is produced by a variety of cells including endothelial cells, 
fibroblasts, keratinocytes, T -cells, mast cells, monocytes and macrophages. It is 
involved in physiological processes such as hematopoiesis as weil as in 
pathological processes e.g. acute phase response, tumorigenesis and host defence 
reactions. 
In hematopoiesis, IL-6 plays a crucial role at different stages. For example IL-6 
induces the entry of dormant primitive stem cell into the cell cycle (Ikebuchi et 
al., 1987; Koike et al., 1988) supports the proliferation of primitive 
hematopoietic precursors (Suda et al., 1988; Miura et al., 1993), supports the 
proliferation of granulocyte/macrophage progenitors (Wong et al., 1988), 
stimulates the differentiation of megakaryocytes (Ishibashi et al., 1989) and is 
required for B cell maturation (Kishimoto and Hirano, 1988) and activation of 
T -cells (V an Snick, 1990). 
IL-6 synergises with several other cytokines such as IL-1, M-CSF, GM-CSF 
and IL-3, e.g. with IL-1 in B-cell differentiation (Vink et al., 1988) with M-
CSF in macrophage formation (Bot et al., 1989), with GM-CSF in the 
differentiation of granulocyte and monocyte precursors (Hoang et al., 1988) and 
with IL-3 in the proliferation of multipotential progenitors (Ikebuchi et al., 
1987). These observations are underlined by the fact that in IL-6 deficient mice 
the proliferation and differention of hematopoietic progenitors are strongly 
decreased (Bemad et al., 1994). 
In acute phase response, IL-6 induces acute phase proteins (Geiger et al., 1988), 
enhances fever (Helle et al., 1988) and triggers the release of the 
adrenocorticotropic hormone (Marinkovic et al., 1989). 
Several observations suggest a role of IL-6 in tumorigenicity. For example, IL-
6 enhances the growth of B-cell hybridomas, mouse plasmacytoma and 
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myelomas, which suggests that IL-6 may act as a tumor growth factor (Astaldi 
et al., 1980; Nordan and Potter, 1986; Klein, 1990a; Klein, 1990b; Hirano et 
al., 1992). In support for this assumption, plasmacytomas transfected with IL-6 
cDNA were found tobe dramatically more tumorogenic then the parental.cells 
01 an Snick, 1990). Besides its effects on proliferation, IL-6 induces the 
production of matrix-metalloproteinases (MMP-2 and MMP-9) which are 
important for the pathogenesis of some Iymphomas (Kossakowska et al., 1999). 
IL-6 disregulation is linked to various diseases. For example, overproduction of 
IL-6 is observed in proliferative diseases such as the Lennert«s T -cell 
lymphoma, a disease characterised by a massive macrophage infiltration of the 
lymphomatous tissue (Shimizu et al., 1988). Disregulation of IL-6 can cause 
autoimmune diseases such as glomerulonephritis and plasma cell neoplasias 
(Hirano, 1992; Horii et al., 1993). IL-6 production by malignant tumours 
accounts for the development of the autoimmune syndrom in cancer patients 
(Y oshizaki et al., 1992). 
IL-6 production is stimulated by viral or bacterial infections, by HA and by 
various cytokines such as IL-1, TNF-a, IL-3, GM-CSF, platelet derived factor 
(Shalaby et al., 1989; Van Damme et al., 1987; Kohase et al., 1987; Bemasconi 
et al., 1995; Tuyt et al., 1996). 
1.2.8 Experimental hematopoietic systems 
In order to study mechanisms which regulate blood cell production, several 
systems were developed that allow to study the different steps of hematopoiesis 
in vitro. 
1.2.8.1 In vitro differentiation of embryonie stem cells (EC) 
One system corresponds to the embryonie stem cells (ES cells) grown in vitro. 
ES cells are totipotent cells derived from the inner cell mass of the developing 
blastocysts (Evans and Kaufman, 1981 ). When those cells are cultured on 
embryonie fibroblasts or in the presence of the leukaemia inhibitory factor 
(LIF), they retain their totipotent capacity (Williams et al., 1988). 
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Differentiation of ES cells can be induced by several means in vitro. For the 
investigation of hematopoiesis, ES cells are cultured on stromal cells. In this 
case stromal cells provide the necessary microenvironment for the development 
of hematopoietic cells in the embryonie body (EB), which develops from the 
ES cells (Keller et al., 1995). 
The mo1ecu1ar mechanisms involved in the establishment of the hematopoietic 
system in vivo are also functioning in the deve1opment of the EBs (Burkert et 
al., 1991; Schrnitt et al., 1991). Therefore, the ES/EB system is especially 
useful for defining the earliest steps of hematopoiesis, corresponding to the 
commitment of the precursor populations and for analysing the genes involved 
in this process. 
1.2.8.2 LTBMC 
Another system to investigate hematopoiesis in vitro is the so-called long term 
hone marrow cultures (L TBMC). According to the culture conditions, one can 
study myeloid or lymphoid differentiation in murine L TBMC or myeloid 
differentiation in LTBMC derived from human bone marrow (Dexter et al., 
1977; Whitlock and Witte 1982; Whitlock et al., 1984). The composition of the 
medium, the temperature and the establishment of the stromal 1ayer determine 
whether myelopoiesis or 1ymphopoiesis is triggered in the murine L TBMC. 
1.2.8.3 Hematopoiesis -supporting stromal cell lines 
Stromal celllines can mirnie in part the hematopoietic support provided by the 
stromallayer in L TBMC. Since they originate from different stromal cells such 
as fibroblast, preadipocytes and endothelial cells they reflect the heterogeneity 
ofthe bone marrow stroma (Deryugina and Muller-Sieburg, 1993). They differ 
in their morphology, in the production of cytokines and of ECM components. 
This explains their ability to support different types of hematopoietic cells. 
Therefore different cell lines are used to study steps of certain lineage 
differentiation, to examine signalling events which are leading to the activation 
of particular transcription factors and/or to the production of particular 
cytokines. 
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1.2.8.4 MS-5 cellline 
One of such supportive hematopoitic stromal cell lines is the munne hone 
marrow derived stromal cellline MS-5. This cellline is derives from adherent 
layer of LTBMC (Itoh et al., 1989) and can support the growth and 
proliferation of hematopoietic stem cells and progenitor cells but also of some 
progenitor cell lines (Suzuki et al., 1992; Issaad et al., 1993; Auffray et al., 
1994; Nishi et al., 1997; Berthier et al., 1997). The supportive property of MS-
5 cells can be explained by the production of a number of molecules critical for 
hematopoiesis. MS-5 cells produce the ECM components fibronectin, laminin, 
collagen type 1, heparin sulfate and chondroitin sulfate proteoglycans (Drzeniek 
et al., 1997) and basal Ievels of cytokines such as IL-6, GM-CSF and SCF 
(Suzuki et al., 1992). MS-5 cells also produce stromal cell- derived factor 1 
(Bleul et al., 1996), which was previously implicated in the direct migration of 
lymphocytes and nerve growth factor, which together with SCF is required for 
the proliferation of the human progenitor cellline UT -7 on MS-5 cells (Auffray 
et al., 1996). 
To trigger hematopoiesis, a close contact between the MS-5 cells and progenitor 
cells seems to be essential. In some instances such a close contact is mediated via 
HA binding, e.g. for the myeloid KG562 cell line (Moll et al., 1998). For 
another cellline ELM-1-1 cell-cell contact with MS-5 cells also appears to be 
required for their proliferation, but in that case this contact seems nottobe HA-
dependent (Sugimoto et al., 1994). 
1.3 The aims of the project and system used 
The basis for this work was the observation that HA treatment of L TBMC 
stimulates the production of progenitor cells and mature cells. HA treatment 
induces signalling that Ieads to the production of IL-1ß and IL-6 cytokines. To 
gain a mechanistic understanding how HA stimulates cytokine production, we 
wanted to establish a simple system, composed of cell lines, which mirnies at 
least some steps of L TBMC. As a substitute for stromal cells we took the 
stromal cell line MS-5, which supports steps of hematopoiesis in several 
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systems, including some progenitor cell lines. As progenitor cells we used the 
erythroleukaemic progenitor cell line TF-1, which requires for its growth the 
cytokines GM-CSF or IL-3 cytokines andrespondsalso to IL-6. We aimed to 
investigate the responsiveness of MS-5 to HA, study the cytokine production in 
these cells and eventually elucidate the mechanism of IL-6 regulation. This 
response of MS-5 cells to HA should be compared with the ability of MS-5 cells 
to support the progenitor cellline TF-1. 
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2 Materials and Methods 
2.1 Materials 
All general chemieals were supplied from Merck (Darmstadt), Carl Roth 
GmbH & Co (Karlsruhe }, Sigma Chemie GmbH (Diesenhofen) and were of 
highest purity grade. The HA (from rooster comb) and other polysaccharides 
were dissolved in H20 and then incubated for 10 min at 95jC. 
2.1.1 Mice 
C57bl/6 mice were provided from Jackson Laboratories (USA}, kept under 
specific pathogen-free conditions and used for experimental passage at the 
age of 8-12 weeks. 
2.1.2 Celllines and mediums 
All cells were maintained in a 37°C incubator in a humid atmosphere with 5% 
C02. Cell stocks were maintained at -80°C and in liquid nitrogen. Trypsin 
was obtained from Difco Laboratories (Detroit, USA) and diluted to 0,25% in 
15 mM sodium citrate, 134 mM potassium ch1oride. EDT A (Merck, 
Darmstadt) was used as a 5 mM solution in PBS. 
The MS-5 cell line is bone marrow derived stromal cell line (ltoh et al., 
1989). MS-5 cells were maintained in Alpha medium containing 10% FCS 
and 2mM Glutamin. 
The TF-1 cellline is a CD34+human erythro-myeloid progenitor cellline. 
TF-1 cells depend for the growth on either GM-CSF, ll..-3, ll...-6 and for the 
differentiation on erythropoietin (Kitamura et al., 1989a; Kitamura et al., 
1989b; Kitamura et al., 1991). TF-1 cells were cultured in RPMI 1640 
medium supplemented with 10% FCS and 500 U/ml of human recombinant 
GM-CSF. 
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The HA9 cellline (a kind gift of D. Naor) is a clone from a mouse T-cell 
Iymphoma LB cellline which is constitutively binding hyaluronic acid. HA9 
cells were maintained in RPMI 1640 medium containing 10% FCS, 10 mM 
Hepes (pH=7 ,4), 1% non-essential amino acids, 1 mM sodium pyruvate, 
lmg/ml insulin, 0,05 mM ß-Mercaptoethanol. 
2.1.3 Plasmids and constructs. 
PGL2 vector (Promega); p3xKB-§Glo-TATA-luc ( 3xNF-1CB) and §Glo-
TATA-luc (vector control) were kindly provided by Dr.Weih; Raf-C4 
dominant-negative and Raf-wt constructs (Bruder et al., 1992); p50pcDNAl 
(Invitrogen); p65/RelApcDNA1 (Invitrogen) 
IL-6 promoter deletion and point-mutated constructs, containing the luciferase 
reporter gene, were the kind gift from Dr.Vellenga: 
Name Description 
1 )piL6luc( -602) - 602 bp upstream of IL-6 transcription start 
2)p1L6luc(-298) - 298 bp upstream ofiL-6 transcription start 
3)p1L6luc( -235) - 235 bp upstream ofiL-6 transcription start 
4 )piL6luc( -169) - 169 bp upstream of IL-6 transcription start 
5)p1L6luc(-122) - 122 bp upstream ofiL-6 transcription start 
6)p1L6luc( -60) - 60 bp upstream of IL-6 transcription start 
7)piL6lucNF-1CBm - 602 bp upstream ofiL-6 transcription start, 
- NF-KB mutated site. 
8)piL6lucNF-IL-6m - 602 bp upstream ofiL-6 transcription start, 
- NF-IL-6 mutated site. 
2.1.4 Radiochemicals. 
CHJ Thymidin 
[p32] dCTP 
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2.1.5 Primers 
All primers were produced and HPLC purified by MWG biotech (Ebersberg) 
or Birsner&Grob Biotech GmbH. 
2.1.5.1 Primers used for CD44 exon-specific RT -PCR analysis 
C13 5'-AAG ACA TCG ATG CCT CAA AC-3' 
C2A 5'-GGC ACT ACA CCC CAA TCT TC-3' 
constant region, oligo3' 
constant region, oligo5' 
pV2 5'-GAT GAC TAC CCC TGA AAC AC-3' variant region, oligo5' 
pV3 5'-ACG GAG TCA AAT ACC AAC CC-3' variant region, oligo5' 
p V 4 5'-TGC AAC TAC TCC ATG GGT TT -3 variant region, oligo5' 
pV5 5'-TAT AGA CAG AAA CAG CAC CA-3' variant region, oligo5' 
pV6 5'-TGG GCA GAT CCT AAT AGC AC-3' variant region ,oligo5' 
pV7 5'-CTG CCT CAG CCC ACA ACA AC-3' variant region, oligo5' 
pVS 5'-CCA GTC ATA GTA CAA CCC TT-3' variant region, oligo5' 
pV9 5'-CAG AAC TTC TCT ACA TTA CC-3' variant region, oligo5' 
p V10 5'-GGT CGA AGA AGA GGT GGA AG-3' variant region, oligo5' 
GAPDH5' 5'-GTT CGA CAG TCA GCC GCA TCT-3' control GAPDH 
GAPDH3'-5-TTC TCC ATG GTG GTG AAG ACG-3' control GAPDH 
2.1.5.2 Primers used for cloning the IL-6 promoter construct 
piL61uk(1,3) 
IL65p 5 '-GAG CTC GAG GGA TCC TGA GAG TGT GT -3' 
IL63p 5'-CTC AGA TCT AGC GGT TTC TGG AAT TGA-3' 
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2.1.6 . Antibodies 
2.1.6.1 Primary Antibodies 
Name Descri~tion Supplier~eference 
KM81 anti-mouse CD44 rat ATCCTffi241 
mAbs HA-binding domain 
KM81 (Fab')2 Eurogentee Bel S .A. 
IM7 anti-mouse/human pan PharMingen 
CD44 rat mAbs lgG2b 
ERK-112 rabbit poly Abs Santa Cruz, USA 
p38 rabbit poly Abs Santa Cruz, USA 
SAPK/JNK rabbit _poly Abs New England Biolabs 
Phospho ERK -112 rahbitpoly Abs New England Biolabs 
Phospho p38 rabbit poly Abs New En_gland Biolabs 
Phospho SAPK/JNK rabbit poly Abs New England Biolabs -
Name Descri_ption Supplier~eference 
VFF4 anti-human CD44v6 munne Bender+Co Ges GmbH 
mAbslgG2b 
VFF8 anti-human CD44v5 munne Bender+Co Ges GmbH 
mAbs lgGl 
VFF14 anti-human CD44v10 munne Bender+Co Ges GmbH 
mAbslgGl 
VFF16 anti-human CD44v10 munne Bender+Co Ges GmbH 
mAbs lgGl 
VFF17 anti-human CD44v7-8 munne Bender+Co Ges GmbH 
mAbs IgG2b 
VFF18 anti-human CD44v6 munne Bender+Co Ges GmbH 
mAbs lgGl 
CD44-FITC anti- mouse CD44 PharMingen 
CD44- PE anti- mouse CD44 PharMingen 
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2.1.6.2 Secondary Antibodies. 
Name Description SuppliernReference 
RabbitHRP goatlgG Dako, Harnburg 
MouseFITC .g_oat Ig_G Phanningen 
Mouse PE rabbit lgG Dako, Harnburg 
RatFITC goat lgG Phanningen 
Rat PE goat lg(H+L) Phanningen 
2.2 Methods 
A number of protocols and prescriptions for commonly used buffers were 
taken from the Labaratory Manual of Maniatis et al. (Maniatis et al., 1989) 
and from the Current Protocols in Molecular Biology (Ausubel et al., 1989). 
2.2.1 Restrietion endonuclease digestion of DNA 
DNA was digested at a final concentration of 1-5 Jlg/Jll. Digestion was 
performed with 3-5 units of enzyme per 1 J..Lg DNA in the buffer 
recommended by suppliers.The reaction was maintained at 37°C for 2 hours 
till 0/N and terminated by phenol/chloroform extraction and ethanol 
precipiation.The digestion products were analysed by agarase gel 
electrophoresis. 
2.2.2 Phenol/chlorophorm extraction 
To remove contaminating proteins from nucleic acids, a mixture of Tris 
buffered phenol, chloroform and isopropanol (2-propanol) at a ratio 25:24:1 
was added and vortexed in. The phases were separated by centrifugation at 
14000 rpm for 5 min. The upper phase, containing the nucleic acids was 
transferred into a new tube and used for a next round of extraction with 
chloroform/isopropanol (24: 1 ). 
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2.2.3 Isolation of DNA fragments from agarose gel 
a) Direct method of DNA isolation from agarose gel 
The necessary DNA band was cut out from the gel with a scalpel under long 
wave UV light. The gel strip, containing the DNA, was placed into a pierced 
0,5 ml reaction tube containing glass wool, which in turn was placed inside a 
1,5 ml Eppendorf tube and centrifuged at 12000 rpm for 30 min. The DNA 
was collected in the reaction tube, leaving the agarose caught in the glass 
wool. The DNA was then extracted with phenol chloroform and precipitated 
with ethanol. 
b) EasyPure Kit (Biozyme) DNA isolation 
The necessary DNA band was cut out and the gel piece was added to 3 
volumes (w/v) of Salt Bufferand incubated for 15 min at 65jC. After adding 
binding resin the mixture was incubated for 5 min at R T. The resin with 
bound DNA was washed twice with ethanol and air dried. The DNA was 
diluted with bidist. H20 or TE buffer (10 mM Tris-HCI, pH=8,0; 1 mM 
EDTA). 
2.2.4 Precipitation of nucleic acid 
The precipitation of DNA and RNA was done by adjusting the final salt 
concentration of the reaction mixture to 300 mM using 3M Na-acetate. The 
precipitate was pelleted by centrifugation at 14000 rpm at 12°C for 30 min, 
washed twice with 75% ethanol and allowed to airdry for 15 minutes. 
2.2.5 Determination of nucleic acid concentration 
The concentration of nucleic acids was determined by measuring their OD 
(optical density) at 260 and 280 nm. One OD26onm is equvalent to 50 ).lg/ml of 
double strained DNA and 40 J.tg/ml of RNA. The OD2aonm is an indicator of 
the purity of the nucleic acid and should have approximatly 50% of the value 
of0D260nm. 
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2.2.6 Size separation of nucleic acid by agarose gel electropboresis 
The required amount of agarose was dissolved in T AE buffer (20 mM Tris-
HCl, 10 mM acetic acid, 1 mM EDTA, pH=8,3 ) and boiled. The ethidium 
bromide was added until the final concentration was 0,3 J.Lg/ml. The gel was 
poured into a horizontal (13,5x8 cm) chamber containing the appropriate 
number and size of the teeth to make loading slots. When set, the gel was 
covered with T AE buffer and DNA samples were loaded into the wells using 
load}ng buffer (10 mM EDTA, 10% v/v glycerol, 0,1% w/v SDS, 0,02% 
bromphenol blue). The migration of DNA was visualised by UV ligh 
transilluminator. 
2.2.7 Preparation of competent cells 
A single colony of E.coli DH5a. was transferred into 3 ml of LB medium (1 0 
g/1 tryptone, 5 g/1 yeast extract, 5 g/1 NaCl) and incubated 0/N at 37°C with 
shaking (220 rpm). 4ml of the 0/N culture were taken to innoculate 400 ml of 
LB medium, grown to an OD59onm of 0,375 and incubated on ice for 15 min. 
The bacteria were pelleted by centrifugation at 3600 g for 10 min at 4 °C, 
pellet was resuspended in 20 ml of ice-cold 0,1 M CaC12 and incubated on ice 
for 15 min. The process was repeated and the pellet was finally resuspended 
in 2 ml of ice-cold CaC12 with 10% glycerol. 
The bacteria were kept in 80J.d aliquots at -80iC. 
2.2.8 DNA ligation 
Ligation reaction was usually performed in a volume of 20 Jll. Usually, 100-
200 ng of DNA fragment were mixed with 300-500 ng of vector DNA and 
with 2 J.Ll of 10x Ligase buffer. 1 J.Ll of T4 ligase was added and the reaction 
was performed 0/N at 16 i C. 
2.2.9 Transformation of competent bacteria 
The transformation was done by electroporation using the Gene Pulser from 
Biorad. Usually, 1 fll of a ligation mixture was added to 40 Jll of 
electrocompetent cells and incubated on ice for 1 min. Cells were transferred 
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into pre-cooled electroporation cuvette (0,1 cm, BioRad) and pulsed at 1,8 
kV. Immediately after pulsing, the cells were supplemented with 1 ml SOC 
medium (20 g/1 Bacto trypton, 5 g/1 Y east extract, 0,5 g/1 NaCI, 2,5 mM KCI, 
10mM MgC12, 10 mM MgS04, 2mM Glucose) incubated at 37°C for 45 min 
and plated ( 100 J.Ll of the cell mixture) on LB- agar plates ( 1% Bacto trypton, 
0,5% Yeasr extract, 1% NaCl, 1% Agar) with the appropriate antibiotic. 
2.2.10 Small scale plasmid preparation (Miniprep) 
3 ml of LB mediom containing the appropriate antibiotic were inoculated with 
a single bacterial colony and incubated 0/N at 37°C. 0/N culture was 
centrifuged for 5 min at 14000 rpm; the pellet was resuspended in 150 f.Ll of 
GTE solution (50 mM glucose, 25 mM Tris-HCI, pH=8,0) and incubated on 
ice for 5 min. After this, 200 J.Ll of the Iysis buffer (0,2 M NaOH and 1% w/v 
SDS) were added, briefly vortexed and incubated again on ice for 5 min; 150 
f.ll of 3M Na-acetate, pH=5,2 were added, the contents mixed by inversion of 
the tube and incubated on ice for 5 min. After 15 min of centrifugation at 
14000 rpm, the supematant was transferred into a tube containing an equal 
volume of phenol/chlorofonn, vortexed and centrifuged for 5 min at 14000 
rpm. The aqueous phase containing the DNA was removed to a fresh tube and 
precipitated with lml of pre-cooled ethanol and 55 J.!l of 3M NaAc. The 
DNA pellet was air dried and resuspended in 20 J.Ll of TE buffer (10 mM 
Tris-HCI, pH=8,0; 1 mM EDTA). 
2.2.11 Large scale plasmid preparation (Maxiprep) 
The large scale plasmid preparation was perfomed using the Qiagen Kit. A 
single bacterial colony was picked and transferred into 5 mi of LB medium 
with the appropriate antibiotic, and incubated for several hours at 37°C. 1 ml 
of this medium was inoculated into 500 ml of LB medium with antibiotic and 
incubated 0/N at 37°C. The bacteria were pelleted by centrifugation at 6000 
rpm at 4°C for 15 min and resuspended in 10 ml of PI buffer (50 mM Tris-
HCI; 10 mM EDTA; 100 J.Lg/ml RNase A). Bacteria were lysed by addition of 
P2 buffer (200 mM NaOH, 1 % w/v SDS), carefully mixed and incubated for 
5 min at RT. 10 ml of P3 buffer (2,55 M KAc, pH=4,8) were gently mixed in 
36 
________________ ____,Materials and Methods 
and after 20 min of incubation on ice the precipitated material was centrifuged 
down at 12000 rpm, at 4 oc for 30 min. The supematant was transferred to a 
Qiagen-tip 500 column, pre-equilibrated with QBT solution (750 mM NaCl, 
50 mM MOPS, 15% v/v), and allowed to drip through. 
The bound DNA was washed twice with 30 ml of QC solution (1M NaCl, 50 
mM MOPS, 15% v/v ethanol, pH=7 ,0) and eluted with 5 ml of QF buffer 
(1,25 M NaCl, 50 mM MOPS, 15% v/v ethanol, pH=8,2) and precipitated 
with 12 ml of isopropanol. After a washing step with 70% ethanol the DNA 
pellet was resuspended in 200 J..Ll TE. The amount of obtained DNA was 
detennined by measuring its OD (optical density) at 260 nm. 
2.2.12 Radioactive labelfing of DNA probes 
Radioactive labeHing of DNA probes was done with the ReadyPrime kit 
(Amersham Life Science) using [p32]-dCTP (Amersham Buchler GmbH, 
Braunschweig, 370 Mbq/ml, 10 mCilml) according to the manufacturers 
protocol. Unincorporated nucleotides were removed from Iabelied DNA using 
Chromospin+STE-100 columns (Clontex Laboratories, Inc.). 
2.2.13 Polymerase Chain Reaction (PCR) 
Usually the PCR was performed in a total volume of 10-100 J..Ll; the PCR 
mixture consisted of 1 pmol of 3' and 5' primer(s), 250 J.!M of dNTP mix (10 
mM of each: dATP, dCTP, dGTP, dTIP), lx appropriate suppliers buffer 
with a defined concentration of MgC12, 1-4 U of Taq polymerase (prepared by 
J.Moll) and variable amounts of DNA. The reaction was carried out in the 
commercially available PCR machine (Peltier Thermal Cycler, MJ Research). 
Specific cycling parameters were used depending on the application. 
For cloning the 1,3 kb part of the IL-6 promoter following parameters were 
used: 
94°C lmin 1 c~cle 
94°C lmin 
56°C Imin 30 cycles 
72°C Imin 
The PCR products were analysed using gel electrophoresis. 
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2.2.14 CD-44 exon specific RT -PCR analysis. 
Poly A +RNA was prepared from the MS-5 cells and used for single strain 
cDNA synthesis. 
1-2 J.tg ofpoly A+RNA were mixed with 500 ng of oligo(dT)12_18 primer in a 
total volume of 12 J.tl, heated to 70°C for 10 min and rapidly chilled on ice. 
The mixturewas supplemented with 4 J.tl of 5x firststrand reaction buffer, 2 
J.tl of 0,1 M DTT and 1 J.tl d.NTP mix (10 mM of each: dATP, dCTP, dGTP, 
dTTP). 1 Jll of SuperScript reverse transcriptase (Gibco BRL) was added just 
before incubation and the reaction was performed at 42° for 1 hour. The 
reaction was terminated by heating the mixture to 94°C for 3 min and placing 
the tube on ice. This frrst strand reaction was stored at -20°C and used later 
for RT -PCR reaction. 
RT -PCR reactions were performed as described for normal PCR with the 
exeption that first strand cDNA was used as template DNA. 
The following PCR parameters were used for CD44 exon-specific RT -PCR: 
94 oc 10 min 1 cycles 
30sec 
1 min 35 cycles 
The PCR was performed in total volume 100 J.L].. 
The mixture consisted of: 
2,5 Jll cDNA, 
2 J.ll 
2 J.ll 
10 Jll 
2,5 Jll 
8 J.ll 
0,5 J.ll 
72,5 Jll 
oligo 3' 
oligo 5' 
lOxbuffer 
dNTPs 
25mMMgC12 
Taq polymerase 
bidest. H20 
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C2A primer located in the 3' constant region of CD44 was used as oligo 5'. 
C13 primer located in the 5'constant region of CD44 and individual variant 
exon-specific primers (pV1-pV10) was used as oligo3'. GAPDH5' and 
GAPDH3' primers were used for the positive control. The PCR products were 
analysed by agarose gel electrophoresis. 
2.2.15 DNA isolation 
For the isolation of total genomic DNA, 750 J..Ll of proteinase K buffer (50 
mM Tris-HCl, pH=8,0; 100 mM EDTA; 100 mM NaCl; 1% SDS w/v; 0,5 
mg/ml proteinase K) were added to the cell pellet ( or to the 2cm piece of 
mouse tail) and incubated 0/N at 55°C. The resulting suspension was 
supplemented with 250 J..Ll of 6M NaCl and mixed for 5 min with an 
Eppendorf mixer. Contaminating material was pelleted by 5 min 
centrifugation at 14000 rpm and 750 Jll of the supematant (without top phase 
and pellet) were transferred into the new tube. The DNA was precipitated 
with an equal volume of isopropanol, washed with 75% ethanol and incubated 
with 300 J..Ll of TE buffer for 2 hours at 37°C. The amount and quality of the 
obtained DNA were analysed on an agarose gel and by measuring its OD at 
260 nm. 
2.2.16 Isolation of total RNA 
TRI REAGENT (Sigma) was used for the isolation of total RNA and 
simultanious isolation of DNA and proteins. Cells were directly lysed with 1 
ml of TRI-REAGENT on 9,4 cm culture dishes. The aqueous phase was 
transferred to a fresh tube and 0,2 ml of chlorophorm and 0,5 ml of 
isopropanol was added. Sampies were incubated for 5 -10 min at RT and 
centrifuged at 14000 rpm for 10 min at 4°C. The pellet was washed with 1ml 
of 75% ethanol, air dried and dissolved in bidist. H20. The amount of obtained 
RNA was determined by measuring its OD at 260 nm. 
2.2.17 Isolation of Poly A + RNA 
Cells were washed twice with PBS and harvested from 15 cm dishes using 10 
ml of STE-SDS buffer (100 mM NaCl, 20 mM Tris, pH=7,4; 10 mM EDTA; 
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0,5% w/v SDS) containing 300 mg/ml proteinase K. The cell mixture was 
homogenised with a ultraturax and incubated at 55°C for 30 min. After the 
incubation, the solutionwas supplemented with 1ml of 5 M NaCI and 100 f.!g 
Oligo-dT -cellulose. The suspension was rotated 0/N at RT to permit binding 
of poly A + RNA. Oligo-dT -cellulose was centrifuged for 3 min at 2000 rpm at 
12°C and washed 3 times with 10 ml HSB buffer (300 mM NaCI; 10 mM 
Tris, pH=7,4; 5 mM EDTA; 0,1% w/v SDS) and once with distilled H20. 
In order to elute DNA, Oligo-dT -cellulose was washed 3 times with H20; 
After each centrifugation the supematant was collected in fresh pre-cooled 
tube. Once completed, RNA was precipitated by addition 2,5 volumes of 
ethanol, 200 f.!l NaAc and 6f.!l tRNA as a carrier and incubated at -20°C 0/N. 
RNA was pelleted by 30 min centrifugation at 10500 rpm in a Beckman 
Swing out rotor at 4 °C, washed once with 75% ethanol and resuspended in 
bidest. H20. The amount of the RNA obtained was determined by measuring 
its OD at 260 nm. 
2.2.18 Northern blot hybridisaöon 
Usually 5 ).11 of RNA solution {lJ.Lg/f.!l) were mixed with 15 f.!l of 
formaldehyde denaturing buffer (50 f.!l IOxMOPS, 87,5 f.!l 37% viv 
formaldehyde, 250 Jll formamide, 3 f.!g/ml ethidium bromide) and denaturated 
at 65°C for 15 min. Sampies were suplemented with 2 f.!l of 10x loading 
buffer (10 f.1l 0,5 M EDTA, 5m150% glycerol, 0,1 % w/v bromphenol blue) 
The 100 ml of RNA-gel- mix consisted of 1g agarose, 10ml10xMops(41,85g 
MOPS, 6,8g NaOAc x 3 H20, 20 ml 0,5 M N~EDTA in 1 L H20, pH=7,0), 
3,5 ml formaldehyde, 85 ml bidest. H20). The gel was poured into a chamber 
with the comb containing the appropriate nurober and size of the teeth to 
make loading slots. When set, the gel was covered with 1xMOPS running 
buffer and the RNA samples were loaded into the wells. The migration of 
RNA was visualised by a UV light transilluminator and photographed. The 
gelwas blotted 0/N on a Hybond N+ membrane with 20 x SSC. The RNA 
was covalently crosslinked to the active OH groups in the membrane by a UV 
stratalinker 2400. 
Hybridisation was performed in Church buffer (0,25 M NaP04, 7% w/v SDS, 
1 mM EDTA pH=8,0) 0/N at 65°C. 
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Filter was washed 2 times with Church buffer and once with 1% SDS/1x SSC 
at 65°C. The filterwas sealed in a plastig bag and exposed to an Amersham 
Hyperfilm or to Phosphorimager screen. 
2.2.19 Transient transfection 
The transient transfections were performed by electroporation using 
Electroporation dense pulse. 
One day before use the cells were replated a in 9,4 cm culture dishes and 
allowed to reach 70% confluence. After trypsinisation, cells were resuspended 
in 400 J.il of medium containing 10% FCS, mixed with 2-10 J.Lg DNA and 
transferred to the pre-cooled 0,4 ml cuvettes; they were pulsed at 270V, 
250J.LF, immediately supplemented with 400 J.Ll of FCS and plated in 10 cm 
culture dishes. The transformation efficiency was monitared by co-
transfection with GFP (green fluorescence protein) and checked 24-48 hours 
after electroporation by F ACS or fluorescent microscopy. 
2.2.20 Measurement of luciferase activity 
The cells used for assay were growing in 9,4 cm dishes. After removing the 
medium, the cells were washed twice with PBS without Ca2+ and Mg2+ and 
incubated with 400 J.Ll of Iysis buffer (0,1 M Tris acetate, pH=7,5, 2 mM 
EDTA, 1% Triton X-100 v/v) on ice for 20 min (with occasional rocking). 
The cell lysates were collected with the rubber policemen into precooled 
tubes, and cleared by 5 min centrifugation at 12000 rpm. To determine the 
luciferase activity, 100 J.LI of the lysate were transferred to a reading tube. The 
measurement was done by a Luminator (Berthold, Wildbad) with 
autoinjection of 350 J.Ll of assay buffer (1 mM DTT, 1 mM ATP in 
glycylglycine buffer (25 mM GlyGly, 15 mM MgS04 and 4 mM EGTA) and 
100 J.Ll of Iuciferin assay solution (lmM Iuciferin stock solution (0,28 mg/ml) 
in glycylglycine buffer [1:5]). 
2.2.21 Transweil assay 
Adherent cells were cultured in 6-well culture plates until 70% confluence. To 
avoid the direct contact between the two cell lines, the suspended cells were 
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added to the same plates in the presence of transweil filters ( 40 Jlm). In this 
case, cells were still cultured in the same medium volume but separated from 
direct interaction. The supematants were investigated for the amount of 
cytokines using an ELISA kits. 
2.2.22 LTBMC 
Myeloid LTBMCs (Long termhone marrow culture) were established as 
described (Whitlock et al., 1982). In brief, femurs and tibias were removed 
from mice, which were killed by cervical dislocation. Bone marrow cells were 
flushed out of the bones, using Dulbecco medium containing 2% FCS. The 
isolated hone marrow cells were washed twice, counted and cultured in 
DMEM, supplemented with 20 % horse serum (Linaris) and Hydrocortisone 
(1 o-6 M; Sigma) in 6 or 24 weil plates at 33°C in a humid atmosphere 
containing 5% co2. 
2.2.23 ELISA 
Cells were stimulated with HA (100 J..Lg/ml) or other reagents. The supematant 
samples were collected and kept frozen at -80°C. The frozen samples were 
checked by ELISA (Enzyme-linked immunosorbent assay)-kits (Biozol) for 
the presence of different cytokines according to the manufacturer instructions. 
2.2.24 Immunohistochemistry (staining of actin cytoskeleton) 
Cells were washed twice with.PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 
mM EGTA, 2 mM MgC12, pH 6,9), fixed with 2,5% glutaraldehyde (Serva) in 
stabilising buffer (20 mM Hepes, 5 mM EGTA, 2 mM PMSF, 1 mM MgS04, 
1gll Na-Tosyl- L-argininmethylester, 20% v/v Glycerin, pH=6,8) at 37°C for 
15 min. Thereafter cells were treated with 50-100 Jll staining solution (3,3 
mM phalloidine -rhodamine in methanol1:10 in PHEM-buffer) at 37°C for 2 
hours. The staining was visualised by fluorescence microscopy. 
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2.2.25 Flow cytometry 
To investigate the expression of molecules on the cell surface, cells were 
harvested, pelleted and dissolved in FACS buffer (PBS, 3% FCS ). After 15 
min of preincubation, 5x105 cells perprobe were incubated with 10 J.Lg/ml of 
primary antiboilies in FACS buffer (30 min, on ice). After two washing steps 
with PBS, probes were incubated with appropriate FITC-, or PE- labeled 
antibodies and washed twise again. To detect HA-binding, cells were 
incubated with FITC-labeled HA instead of primary and secondary 
antibodies. 
The fluorescence was analysed by F ACS-Star plus flow cytometer (Becton 
Dickinson). 
2.2.26 fH] Thymidin incorporation 
The cells were plated in 96-well plates (105/per weil), allowed to grow 0/N 
and treated with the reagents of interest. [3H] Thymidin was added until a 
final concentration of 1 J.LCilml. After 6 hours the cells were harvested by a 
TOMTBC Harvester (Wallac ADL GmbH) and amount of incorporated 
radioactivity was analysed by 1450 Microbeta liquid scintillation and 
luminiscence counter (Wallac ADL GmbH). 
For proliferation-analysis of TF-1 cells on a MS-5 feeder layer, the MS-5 
cells were allowed to grow until confluence in 6-well plates and were 
irradiated with 900 rad by y-ray. TF-1 cells (105) were added directly on MS-5 
stroma. After 12-24 hours of co-culture, the cells were pulsed with [3H] 
Thymidin for 6 hours, harvested and analysed as discribed before. 
2.2.27 lmmunoblot analysis of proteins (Western blot) 
a) Celllysates 
Cells were grown to confluence, treated with appropriate reagents and 
harvested by scraping with a ruhher policeman in the presence of sample 
buffer (125 mM Tris pH=6,8, 2% w/v SDS, 0,02% bromphenol blue), 
containing 10% glycerol for nonreducing, and 100 mM Dithiothreitol (DTT) 
for reducing conditions. Sampies were boiled for five minutes, sonicated for 
30 seconds and kept frozen at -80°C. 
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b)SDS-PAGE 
Proteins were separated electrophoretically on the basis of molecular weight 
using the method of Laemmli. 
The running gel mixture was poured between glass plates separated with 
special spacers until two thirds full, overlaid with ethanol and allowed to 
polymerase. The stacking gel mixture was poured on top of the running gel. 
The sample wells were formed by appropriate combs placed in the stacking 
gel. The gel was fixed into a vertical running chamber filled with 
electrophoresis buffer (25 mM Tris, 192 mM glycine, 0,1% w/v SDS). 
Running gel mix (25 ml): 
30% acrylamid-bisacrylamide 8,325 ml 
1,5 M Tris pH=8,8 6,25 ml 
20% SDS 0,125 ml 
H20 10,05 ml 
+250 J .tl Ammoniumpersulfate (10% w/v) 
+ 15 J.1l TEMED 
stacking gel mix (20 ml) 
30% acrylamid-bisacrylamide 
0,5 M Tris pH=6,8 
20% SDS 
3,4ml 
.5,00 ml 
0,1 ml 
H20 11,3 ml 
+200 Jll Ammoniumpersulfate (10% w/v) 
+20 J.1l TEMED 
Sampies were run into the stacking gel at 70V and then at 30V overnight or 
140V during the day. 
c) Protein staining with Coomassie Brüliant Blue 
In order to visualise proteins in SDS-PAGE, the gelwas incubated for 1-2 h 
in staining solution (50% methanol, 7,5% acetic acid, 0,2% w/v Coomassie 
brilliant blue R250) and destained for several hours in a destaining solution 
(50% methanol; 7,5% acetic acid) which was changed until the gel 
background is clear. Once completed, the gelwas dried on What 3MM paper. 
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d) Western blotting 
Proteins resolved by SDS-Page were transferred to lmmunobilon-PVDF 
membrane (Milipore, Bedford, UK) using BioRad Transfer chambers 
containing blotting buffer (20 mM Tris, 192 mM glycine, 0,1% w/v SDS, 
20% v/v methanol). According to the size of the protein and the current 
applied transfer time varied from 4-6 hours to 0/N. 
e) Western blot prohing 
The membrane was briefly washed in PBS, preincubated for 1 hour in 
blocking buffer (PBS+5% w/v BSA, 0,1% v/v Tween) and incubated with the 
primary antibody for 1h to 0/N (according the manufacturer instructions for 
the antibody) at 4°C. After 3 washing steps with PBS + 0,1% v/v Tween, the 
· membranewas incubated another hour with the secondary antiborlies at RT 
and washed 3 times again with PBC. The proteins were visualised by ECL 
reaction (Amersham) and exposed to the ECL- Hyperfilm (Amersham). 
2.2.28 CPC precipitation 
a) Biotinylation of cell surface proteins 
Cells were washed three times with ice-cold PBS (without Ca2+, Mg2+) andre-
suspended in freshly prepared 1 mg/ml NHC-biotin/PBS solution (NHS-LC-
Biotin, Pierce) at a concentration 5x105 cells/ml. The cell mixture was 
incubated on ice for 1 hour with additional rocking. After incubation, cells 
were washed 3 times with PBS containing 200 mM of glycine. The 
biotinylated cells were used for CPC precipitation. 
b) Cell preparation. 
Previously biotinylated cells or confluent cells of a 15 cm dish, washed three 
times with PBS were used for the preparation of celllysate. They were lysed 
with 1 ml PBS/0,5% NP40, supplemented with PMSF (1 mM final 
concentration), incubated on ice for 30 min. and centifuged at 14000 rpm, 10 
min in order to pellet insoluble material; the supernatant was taken as the cell 
lysate. 100 J.Ll of celllysate were mixed with 350 J.ll of reducing sample buffer 
and 50 J.Ll1M DTT and stored as a positive control. 
45 
_________________ __,Materials and Methods 
c) Precipitation 
Aliquots (100 J.Ll) of the cell lysates were used for CPC (Cetylpyridinium 
chloride (Sigma chemical co, USA)) precipitation. 
Glycosaminoglycans were dissolved in water to a final concentration of 
lmg/ml. 50 J.Ll of glycosaminoglycan solution were mixed with 100 J.Ll of cell 
lysate and incubated at roorn ternperature for 1 hour.Once cornpleted, 350 J.Ll 
of a 1.4% CPC solution were added to the rnixture and incubated foranother 
hour at RT. Precipitate was pelleted by 10 min centrifugation in a swingout 
rotor and washed 3 tirnes with 1ml of 1 %CPC/30rnM NaCl and disolved in 50 
Jll of reducing sarnple buffer. Sampies were shaked for 30-60 minutes to 
dissolve the pellet cornpletely, boiled and loaded on a SDS-PAGE gel. SOS-
gel was bloted as for a Western blot. In the case of biotinylated cells, the blot 
was probed with HRP coupled to streptavidin (Dianova) and analysed by ECL 
reaction. For CD44 detection the procedure was done at non-reducing 
conditions and the blot was probed with IM7 antibodies. 
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3 Results 
3.1 Part 1: HA mediated cytokine induction in MS-5 cells 
The starting point of this project was the observation that HA, a component 
of the hone marrow environment, can significantly enhance hematopoiesis 
and plays a regulatory role in this process (Khaldoyanidi et al., 1999). 
Exogeneously added HA increases the numher of myeloid and lymphoid 
non-adherent cells in L TBMC and also the total amount of clonogenic cells. 
It was shown that HA acts on hematopoiesis via stromal cells, which respond 
to HA hy upregulation of IL-6 and IL-1 ß cytokines. The enhancing HA 
effect on L TBMC was due to IL-6 cytokine release from hone marrow 
macrophage stromal cells. 
3.1.1 Stromal celllines can support hematopoietic progenitors 
The hematopoietic potential of L TBMC can he partially simulated by a 
system consisting of progenitor cells and hematopoietic stromal cell lines 
(Dorshkind, 1990). To test whether in such a system HA would also 
stimulate cytokine production similarly to the effect in L TBMC we used the 
hone marrow stromal cell line MS-5 and the CD34+ progenitor cell line 
TF-1. 
At first, we tested whether MS-5 cells can support the survival and the 
proliferation of TF-1 cells. Forthis purpose, MS-5 cells were grown up to 
confluence and were suhsequently irradiated hy y-ray (900 rad ). TF-1 cells 
were then seeded on the MS-5 layer and their proliferation was examined at 
different tim es hy the [3H) thymidin incorporation method. TF -1 cells were 
also grown in the presence of recombinant GM-CSF (positive control) in the 
medium and without cytokine addition (negative control). At each time point 
for the last 6 hours thymidin was added. Afterwards cells were harvested and 
incorporated radioactivity was counted. 
After 24 hours we could ohserve a significant difference in proliferation 
between co-culture ofTF-1 cells with MS-5 cells and TF-1 cultures without 
cytokine addition, which became even more pronounced after 36 hours 
(Fig.5). 
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Figure 5. MS-5 feeder layer supports the survival and the 
proliferation of TF-1 cells. MS-5 cells were grown up to confluence and 
irradiated with 900 rad by r-irradiation. TF-1 cel/s ( 105) were co-cultured with 
the MS-5 feeder layer. The proliferation of TF-1 cells was examined with the (lH) 
thymidin incorporation assay. TF-1 cel/s alone and supplemented with rGM-CSF 
were used as negative and positive controls. SO was calculated from results 
obtained from triplicates. 
The TF-1 cells in the absence of cytokines or MS-5 cells did not proliferate. 
TF-1 cells in the presence of recombinant GM-CSF (rGM-CSF) showed 
proliferation as did TF -1 cells grown on MS-5 feeder layer. Thus, we 
conclude that the MS-5 cellline can support the growth of TF-1 cells. This 
result suggests that MS-5 cells produce a basic amount of one of the factors, 
which could support the growth of the TF -1 cell line. Indeed it was 
previously described that MS-5 cells produce GM-CSF and IL-6. Thus the 
MS-5 clone had the desired property to support hematopoietic progenitors, 
an absolute requirement for our further studies. 
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3.1.2 MS-5 cells can bind FITC-Iabelled HA on their surface 
To study the influence of HA on MS-5 cells we examined binding of HA to 
the MS-5 cell line. Cells were pre-treated with hyaluronidase (HA ase) and 
then incubated with FITC- labelled HA. Bound HA was measured by F ACS-
Star plus flow cytometer. The method demonstrated HA binding to MS-5 
cells (Fig.6) . 
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Figure 6. MSmS cells bind HA (FACS staining with FITC-HA). 1 OS cells 
were stained with F/TC Iabeiied HA. The f/uorescence was analysed on a FACS-
Star plus flow cytometer. 
3.1.3 HA specifically stimulates cytokine production by MS-5 cells 
We tested whether MS-5 cells respond to HA treatment by the induction of 
cytokines similarly to bone marrow derived macrophages (BMDM) in 
LTBMC. For this purpose MS-5 cells were grown up to 70 o/o confluency 
and treated with HA. The production of cytokines was measured using 
ELISA kits. HA treatment increased the production of IL-6, GM-CSF and 
IL-4 cytokines, whereas IL-3 and IL-1 ß production was not influenced 
(Fig.7). To further characterise our system we examined the time course and 
concentration dependence of cytokine production induced by HA (Fig.8). 
The first significant increase in cytokine production was seen 6 hours after 
the addition of HA. The maximal increase was reached after 24 hours. The 
specificity of HA action was demonstrated by the fact that a treatment with 
chondroitin sulfate (CS), another glycosaminoglycan, had no effect on MS-5 
cells (Fig.9). 
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Our results indicate that the MS-5 cell line responds to HA treatment by 
upregulation of cytokines relevant for hematopoiesis, particularly of IL-6. 
Although other cytokines are released by MS-5 cells than the ones from 
BMDM, we believe that this difference reflects the reaction of particular 
stromal cell compartments. Therefore, the MS-5 cell line could be an 
excellent model to assess the mechanism of cytokine activation upon HA 
treatment. 
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Figure 7. HA stimulates the production of /L-6, GM-CSF and /L-4 
cytokines in MS-5 cells. Cells were allowed to grow up to 70% confluence 
and were stimulated for 24 hours with 100 J.Lg/ml of HA. The concentration of IL-
6 (A}, /L-4 (8), GM-CSF (C), IL-1ß (D) and /L-3 (E) in the supernatants was 
determined by ELISA kits. SO was calculated from triplicates. 
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Figure 8. HA stimulates the production of cytokines in MS-5 cel/s in a 
time and dose dependent manner. 
A) Time dependent effect of HA on cytokine production. 
8) Stimulation ot MS-5 cultures with different HA di/utions. 
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3.1.4 MS-5 cells can be stimulated by immobilised HA 
HA can induce cytokine release either by binding to and activating its 
receptor on the cell surface or by being uptaken into the cells by a process 
called endocytosis. To distinguish between these two possibilities, we 
performed an experiment using for MS-5 activation HA fixed to the culture 
plates and compared the effect with that of soluble HA. Cytokine production 
in the culture supematants was measured by ELISA (Fig.l 0). Immobilised 
HA induced cytokine production similarly to soluble HA. BSA- covered and 
PBS-treated plates had no influence. The observation that immobilised HA is 
still able to induce cytokines in MS-5 cells, suggests the involvement of a 
receptor-ligand interaction and signaHing from the cell surface. 
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Figure 10. lmmobilised HA can stimulate IL-6 production in MS-5 
cells. The plates were incubated 0/N at 4°C with PBS, 1mg/ml BSA or 1mglml 
HA so/ution and washed 3 times with PBS. MS-5 cells were cultured on the HA-
BSA- or PBS -covered plates for 24 hours. Cytokine concentration in the 
supernatants was measured by an ELISA kit. SD was calcu/ated from results 
obtained from triplicates 
3.1.5 Is CD44 the receptor mediating cytokine induction? 
Since CD44 is the most widely expressed HA receptor, we tested whether it 
accounts for the HA effect on MS-5 cells. We first looked at the expression 
of CD44 isoforms on MS-5 cells. As shown in Fig.ll, a F ACS analysis and a 
CD44 exon specific RT-PCR analysis revealed that MS-5 cells carry the 
CD44 standardisoform and the CD44v9 isoform. 
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Figure 11. MS-5 cells express CD44 mo/ecules on their surface. 
A) FACS staining with anti-CD44 IM? antibodies. 
1 0 5 cel/s were stained with anti-CD44 antibodies. The f/uorescence was 
analysed on a FACS-Star plus flow cytometer. 
B) CD44 exon-specific RT-PCR analysis. 
CD44 exon-specific RT-PCR analysis was performed as described in Materials 
and Methods. The PCR products were analysed by an agarase gel 
e/ectrophoresis. 
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To answer the question whether MS-5 cells bind HA through CD44, we 
performed a F ACS analysis with FITC labelled HA. The CD44 specificity of 
the bindingwas tested with antiborlies that react with the HA-binding domain 
of CD44 (KM81) and thereby prevent HA binding. Pre-treatment of MS-5 
cells with KM81 mAbs antiborlies for 1 hour before addition of HA strongly 
decreased this HA-binding. Thus, we concluded that MS-5 cells bind HA 
mainly via CD44 (Fig.12). 
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Figure 12. Ktyl81 antibodies abrogate HA binding by MS-5 cells. 10 5 
cel/s were stained with FITC-HA with or without pre-treatment with KMB1 
antibodies. The f/uorescence was ana/ysed on a FACS-Star plus flow cytometer 
To determine whether the binding of HA to CD44 is required for the 
induction of cytokines we investigated the effect of the anti-CD44 antiborlies 
KM81 on HA-stimulated cytokine production. The MS-5 cells were pre-
incubated with the antiborlies for 30 min before HA treatment. The pre-
incubation with antiborlies was done at 3 7 j C or on ice ( to avoid the possible 
uptake of the antiborlies by cells ). 24 hours after Stimulation with HA the 
culture supematants were checked for the presence of cytokines. 
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Figure 13. KMB1 mAbs 
do not inf/uence HA-
mediated cytokine 
production. MS-5 cells 
were grown up to 70% 
confluence, pre-treated for 
1 hour with 20 Jlg/ml o f 
KM81 and induced with 100 
Jlglml of HA. After 2 4 
hours the cytokine 
concentration in the 
supernatants was 
measured by an ELISA kit. 
SD was calculated from 
results obtained from 
trip!icates. 
A) /L-6 B) GM-CSF. 
W e showed that under both conditions (3 7 j C or 4 j C), neither IL-6 induction 
(Fig.13) nor GM-CSF induction was repressed by the anti-CD44 antibodies. 
This observation suggests that, despite the involvement of CD44 in the HA 
binding, the HA- induced cytokine secretion in MS-5 cells seems to occur 
through a CD44 independent mechanism. 
3.1.6 Possible involvement of another HA receptor in the induction of 
cytokines response 
We investigated whether other proteins on the surface of MS-5 cells could 
bind HA. Forthis purpose we took advantage of the CPC (Cetylpyridinium 
chloride) precipitation method, which allows to pull down proteins that bind 
glycosaminoglycans (Sleeman et al., 1993). Surface proteins on MS-5 cells 
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were biotinylated and protein lysates were used for the CPC precipitation 
with HA and with CS (as a control). Proteins bound to glycosaminoglycans 
were resolved on a SDS-PAGE gel under reducing conditions, blotted onto a 
membrane and visualised by means ofHRP-conjugated antibodies (Fig.14). 
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Figure 14. CPC precipitation of biotinylated surface profeins from 
the MS-5 ce/1 line. The ce/1 surface profeins were biotinylafed as described in 
Materials and Methods. Protein lysates were incubated with 1 mg/ml of HA, CS o r 
with H20. Bound profeins have been precipitated with CPC solution. Total ce/1 
lysate was used as a positive control. 
9 proteins from MS-5 cells seem to specifically bind HA as compared to CS 
and H20 controls (Fig.14). They are putative receptors for HA and could 
mediate HA signaHing leading to cytokine induction. To demoostrate the 
specificity of the CPC precipitation method, we examined whether CD44 is 
pulled down by HA among the other proteins. In this case the whole 
procedure was performed in non-reducing conditions and CD44 was 
visualised with the IM7 mAb. We observed that two CD44 isoforms can be 
CPC-precipitated from the MS-5 cells protein lysate among other HA-
binding proteins (Fig.15). 
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Figure 15. CD44 is CPC precipitated from the MS-5 ce/1 line. Protein 
/ysates were incubated with 1 mglml of HA, es or with H20. Bound profeins have 
been precipitated with CPC Solution. Total ce/1 /ysate was used as a positive 
control. The blot was probed with pan CD44 (/Ml) antibodies. 
From those observations we conclude that not only CD44, but also other 
proteins on the MS-5 cell surface can bind HA and their binding might be 
decisive for the induction of cytokine production. 
3.1.7 HA stimulation of MS-5 cells Ieads to rearrangment of 
cytoskeleton. 
Extracellular signals affecting cells often result in cytoskeleton. 
rearrangements. In order to investigate whether the cytoskeleton structure of 
MS-5 cells is changed upon HA treatment we stained the cells with 
phalloidine-rhodamine antibodies before and after Stimulation with HA. 
lndeed the treatment of MS-5 cells with HA was accompanied by a 
rearrangement of the cytoskeleton resulting in the appearance of 
lammellopodias and membrane ruffles. The effect was observed already 15 
min after HA-stimulation and Iasted up to 16 hours (Fig.16). 
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Figure 16. HA-mediated cytoskeleton rearrangement in MS-5 cells. 
MSS cells were incubated with 100 Jlg/ml of HA for different times (15 min, 4 
hours, 16 hours). Actin staining was performed with phalloidine-rhodamine and 
was evaluated by fluorescence microscopy. 
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3.1.8 Involvement of ERK and p38 in HA- signalling. 
Extracellular signals received by receptors are further transmitted to the 
nucleus via intracellular signalling cascades finally leading to changes in gene 
expression. These cascades include activation of mitogen activated protein 
kinases (MAPKs) (Su and Karin, 1996) (Fig.17). MAPKs constitute a group 
of serine/treonin specific, proline directed protein kinases. So far several 
distinct MAPKs in vertebrates have been identified including ERK.l/2, 
SAPK/JNK and p38. 
We investigated the possible involvement of members of the protein kinase 
family in mediating cytokine expression in MS-5 cells upon HA treatment. 
The activation of kinases was monitored by their phosphorylation status. MS-
5 cells were incubated in serum-free medium for 24 hours and induced with 
HA for different times. HA treated and non-treated cells were lysed and 
samples were investigated for MAPK activity using antibodies specific for 
the phosphorylated forms of ERK.l/2, p38 and SAPK/JNK. 
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Figure 17. Schematic representation of eukaryotic MAPK signal 
transduction pathways (ERK112, JNKs/SAPKs and p3Bs pathway). 
ATF: activating transcription factor, ERK: extracellular signa/-regulated 
kinase, JNK: Jun-N-terminal kinase, MAPK: mitogen activated profein kinase , 
MAPKK: MAP-Kinase-Kinase, MAPKKK: MAP-kinase-kinase-kinase, MEK: 
MAPKIERK-kinase, MEKK: MEK-kinase, MKK: MAP-kinase-kinase, PAK: p21-
activated profein kinase, RTK: Receptor-Tyrosin-Kinase, SAPK: Stress-
activated Protein Kinase, SEK: SAPK/erk-Kinase, TPA: 12-0-tetradecanoy/-
phorbo/-13-Acetat. 
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Figure 18. HAainduces activation of ERK and p38 MAPKs in MSa5 cells 
and does not influence SAPKIJUN kinase. MS-5 cells were a/lowed to grow 
up to 70% confluence and were starved for 24 hours. Cells were incubated with 
100 J.Lglml of HA for different times and Jysed with profein sample buffer. The 
samples were loaded on the SOS PAGE ge/ in duplicates and ana/ysed b y 
standard wesfern blot procedure with anti- phosphospecific a)ERK, b)p38 or 
c)SAPKIJUN Kinase antibodies. 
SAPK/JNK was not influenced by the HA-treatment (Fig.18). In contrast, 
ERK.l/2 and p38 became activated upon HA stimulation (Fig.18). The period 
of activation for the kinases was between 5-30 and 60-90 min for ERK.l/2 
and between 60-90 min for p38. 
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3.1.9 Kinases inhibitors prevent HA-mediated cytokine induction 
HA treatment of MS-5 cells Ieads to the activation of ERK and p38 kinases, 
two kinases that belong to different signal transduction pathways (Fig.17). 
Using specific kinase inhibitors, we made an attempt to find out which 
pathway is directly involved in the upregulation of the cytokine production. 
The MS-5 cells were pre-incubated with different inhibitors for 30 min 
before HA induction. The culture supematants were checked for the presence 
of cytokines. Wortmanin, a specific inhibitor of PI3 kinase (Okada et al., 
1994) did not influence IL-6 and GM -CSF cytokine production. The specific 
p38 inhibitor SB203580 (Simon et al., 1998) down regulated GM-CSF 
production but did not influence the IL-6 response (Fig.19). ERK activation 
is mediated through specific protein kinases MAPKIERK kinases (MEK) 
(Fig.17). The specific MEK1 inhibitor PD-98059 (Simon et al., 1996) 
strongly decreased IL-6 production and only partially affected the production 
of GM-CSF (Fig.19). To further confirm the involvement of the ERK 
pathway in IL-6 production induced by HA, we also used the inhibitor 
U0126, that also inhibits the ERK activating MAPK kinase MEK (Favata et 
al., 1998). U0126 treatment completely abrogated HA-mediated IL-6 
induction (Fig.20). 
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Figure 19. lnf/uence of inhibitors of signal/ing cascade on HA-induced 
cytokine production by MS-5 cells MS-5 cells were grown up to 70% 
confluence and starved for 24 hours in medium containing 0% FCS. Ce/ls were 
pre-treated for 30 min with 88203580 (25 11M), PD98059 (50 11M) o r 
Whortmanin (1 11M) and induced with 100 Jlglml HA. Cytokine concentration in 
the supernatants was measured by an ELISA kit. 
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These results demonstrate the involvement of MAPKs in the HA-induced 
cytokine response. We conclude that the IL-6 stimulating HA signal in MS-5 
ceHs is transferred mainly through the MEK-ERK pathway and the GM-CSF 
signaHing possibly involves p38 activation. 
3.1.10 Raf dominant-negative mutant downregulates IL-6 production 
To further dissect the signaHing pathway involved in the HA-mediated IL-6 
activation, we examined the contribution of Raf, a kinase upstream of MEK. 
Its possible involvement was tested using a dominant-negative mutant 
(Fig.21). 
MS-5 ceHs were transiently transfected with this Raf-1 -dominant-negative 
mutant or with a Raf-1-wild type construct, before stimulation with HA. 24 
hours after HA addition the supernatants. were tested for the amount of 
cytokine produced. 
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after transfection, starved 
for the next 12 hours in 
medium with 0% FCS and 
stimulated tor 24 hours 
with 100 Jlglml of HA. 
Cytokine concentration in 
the supernatants was 
measured by an ELISA kit. 
The Raf dominant-negative mutant reduced the HA-mediated IL-6 response 
in MS-5 cells by approximately 50%. The transfection efficiency of MS-5 
cells in those experiments was approximately 42% (as controlled by co-
transfection of cells with the green fluorescence protein (GFP). Since only 
the transfected cells can show the Raf dominant-negative effect, we conclude 
that IL-6 induction in all transfectants is completely abrogated. Thus, our 
results place HA-signalling leading to IL-6 production in the Raf-MEK-ERK 
transduction pathway. 
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3.1.11 HAinduces IL-6 mRNA expression in MS-5 cells at the Ievel of 
gene transcription 
To examine whether the increase of IL-6 and GM-CSF expression upon HA 
treatment is due to upregulation of transcription and not due to RNA 
stabilisation, we preincubated cells before HA-stimulation with the 
transcription inhibitor actinomycin D. Actinomycin D could completely 
block the ability of HA to increase the amount of IL-6 specific RNA. This 
result indicates that HA regulates IL-6 in MS-5 cells at the Ievel of 
transcription. In contrast, pre-treatment of the MS-5 cells with actinomycin 
D did not significantly affect HA- dependent GM-CSF increase (Fig.22). 
Therefore GM-CSF production seems tobe due to RNA stabilisation. 
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Figure 22. HA induces /L-6 expression on the transcriptional Ievel. 
MS-5 cel/s were grown up to 70% conf/uence and starved for 24 hours in medium 
with 0% FCS. Cel/s were pre-treated with actinomycin D and induced with 100 
Jlg/ml of HA. After 6 hours RNA was isolated and Northern blot analysis was 
performed. 
A) GM-CSF 
B) /L-6 
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3.1.12 HA enhances IL-6 promoter activity in MS-5 cells 
To further confinn that induction of IL-6 by HA is the result of a 
transcriptional enhancement, we tested whether transfected IL-6 promoter 
constructs also respond to HA treatment. A full length promoter construct 
was cloned from MS-5 DNA using specific 5' and 3' primers (see Material 
and Methods) and fused to the luciferase gene sequence as a reporter gene. 
MS-5 cells were transiently transfected by electroporation with this IL-6 
promoter construct ( or vector control) and stimulated with HA for 24 hours. 
Cell lysates were examined for the amount of luciferase activity. We 
observed that HA could indeed activate the exogenous IL~6 promoter 
construct (piL6luc(1.3)). Surprisingly, a smaller (602 bp) IL-6 promoterwas 
stronger induced by HA than the Ionger promoter construct, which could 
indicate the existence of a negative regulatory cis- elements within the region 
-602Jp to -1.3 kb. In further experiments we used the construct piL6luc(-
602) as an entire promoter construct because of its maximal inducibility 
(Fig.23). Parallel to the activation of IL-6 promoter constructs we always 
tested the activation of the endogenous IL-6 gene by an ELISA assay. 
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Figure 23. HA enhances IL-6 promoter activity in MS-5 cells. MS-5 cel/s 
were transiently transfected by electroporation with /L-6 promoter /uciferace 
reporter constrt.ict. Cel/s were cu/tured 12 hours after transfection, starved for 
the next 12 hours in medium with 0% FCS and stimulated for 24 hours with 1 00 
JLg/ml of HA. After Stimulation cel/s were lysed and analysed for the amount o f 
luciferase profein produced. The mean and SD represent three identical 
experiments. 
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To define which of the sequences in the IL-6 promoter account for the HA 
response, we transiently transfected MS-5 cells with IL-6 promoter 
constructs containing further truncations at the 5'-end: piL6luc(-602), 
piL6luc( -298), piL6luc( -235), piL6luc( -169), piL6luc( -122), piL6luc( -60). 
Deletions up to -169bp in the IL-6 promoter did not significantly reduce 
HA-induced IL-6 promoter activity. Further deletions, to -122 bp and:o -60 
bp (piL6luc(-122) and piL6luc(-60}}, showed no HA response (Fig. 24). 
70 
Results --------------------------------------------------~ 
A) 
100000 
90000 
Cl) 80000 
-·c: 70000 :::J 
-L: 60000 
.!2> 
50000 
Ci) 
.... 40000 0 
:::J 30000 
20000 
10000 
0 
HA + + + + + + 
-602 bp -298 bp 235 bp -169 bp -122 bp - 60 bp 
3,5 
3,0 
c: 2,5 
0 
t5 2,0 :::J 
"'0 
c: 
"'0 1,5 ö 
-0 1,0 
.2 
0,5 
0 
-602 bp -298 bp -235 bp -169 bp -122 bp -60 bp 
Figure 24. The deletion mutants of /L-6 promoter can abrogate HA-
mediated /L-6 activation. MS-5 cel/s were transiently transtected by 
electroporation with IL-6 promoter luciferace reporter deletion constructs. Cells 
were cultured 12 hours atter transfection, starved for the next 12 hours in 
medium with 0% FCS and stimulated for 24 hours with 100 Jlglml of HA. After 
stimulation cel/s were lysed and analysed for the amount of luciferase protein 
produced. The mean and SD represent three identical experiments. 
A) Represents the mean of luciferase relative units. 
8) Represents the mean of fold induction. 
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3.1.13 HA enhances the IL-6 promoter activity in MS-5 cells through 
NF-IL-6 and NF-KB regulatory cis-elements 
In the reg10n between -122bp and -60bp of the IL-6 promoter two 
potential binding sites for transcription factors are removed: at -122bp a 
NF -IL-6 binding site and at -60 bp a NF -ld3 binding site. 
We therefore addressed the question whether both, the NF-IL-6 and the NF-
KB site are important and necessary for HA-mediated IL-6 expression. We 
introduced into the 602 bp promoter construct point mutations in the NF-KB 
binding site and in the NF-IL-6 binding site which should inactivate these 
sites. The mutant constructs were transiently transfected into MS-5 cells and 
the expression of luciferase was tested upon HA treatment. Both mutants 
strongly abolished HA-mediated IL-6 promoter activation (Fig.25). This 
result demonstrates that the NF-IL-6 and the NF-KB regulatory cis-element 
are targets for HA-dependent activation. To test whether NF-KB suffices for 
activation we additionally transfected the MS-5 cells with a construct 
containing 3 times a repeat of an NF-KB cis-element ( 3xNF-kB construct). 
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Figure 25. NF-JCB and NF-IL-6 mutated cis- elements abrogate HA-
mediated activation of IL-6 promoter constructs. MS-5 cells were 
transiently transfected by electroporation with the /L-6 promoter luciferase 
reporter constructs p/L61uc(-602), piL61ucNF-JCBm, p/L6/ucNF-IL-6m. Cells were 
cultured 12 hours after transfection, starved for the next 12 hours in medium 
with 0% FCS and stimulated for 24 hours with 100 }lglml of HA. After 
Stimulation cells were lysed and analysed for the amount of luciferase protein 
produced. The mean and SD represent three identical experiments. 
A) Represents the luciferase relative units. 
B) Represents the mean of fold induction. 
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Figure 26. Construct containing a 3xNF-1CB cis-element can be 
activated in MS-5 ce/ls by HA-stimulation. MS-5 ce/ls were transiently 
transfected by electroporation with 3xNF-1CB luciferace reporter construct. Cells 
were cultured 12 hours after transfection, starved tor the next 12 hours in 
medium with 0% FCS and stimulated tor 24 hours with 100 pg/ml of HA. After 
Stimulation cells were /ysed and ana/ysed tor the amount of Juciferase profein 
produced. The mean and SO represent three identical experiments. 
The result of this experiment, illustrated in Fig.26, suggests that HA can 
directly increase NF-KB mediated transactivation. The NF-KB construct can 
be stimulated by HA, but not to such a high extent as the complete IL-6 
promoter. However, this construct consists of 3 times repeated NF-KB cis-
element. Thereby, in the endogenous IL-6 promoter the cooperative 
involvement ofNF-IL-6 and NF-lCB elements might be necessary. 
Altogether our results indicate that: 
A) HAis a potent inducer ofthe IL-6 gene promoter. 
B) The synergistic transactivation by NF-IL6 and NF-KB factors might be a 
necessary and crucial event in HA-mediated IL-6 gene transcription. 
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3.2 Part 2: SignaHing induced by interaction between MS-5 cells and 
TF-1 cells 
Components of the ECM can be involved in cell- cell communication 
between hematopoietic progenitors and stromal cells. Previously the HA 
mediated adhesion of myeloid progenitor cell lines to the hone marrow 
stromal cellline MS-5 was demonstrated tobe mediated by HA (Moll et al., 
1998). 
Our observation about the regulatory role of HA on the stromal cells and the 
data showing that HA might be involved in progenitor -stromal cells 
adhesion motivated us to investigate a direct interaction between MS-5 
stromal cells and CD34+ TF-1 progenitor cells and later on possible 
involvement of HA in this process. 
3.2.1 TF-1 cells stimulate MS-5 cells to produce cytokines 
We investigated the cytokine production from the MS-5 cells before and 
after co-culturing with TF-1 cells. Since the MS-5 cells are murine cells and 
the TF-1 cells are of human origin, we used species-specific ELISA kits 
which allowed to distinguish which cell line is responsible for the cytokine 
production. Interestingly, we observed that upon co-culture with TF-1 cells, 
the MS-5 cell line can be activated to increase the amount of particular 
cytokines IL-6, GM-CSF and IL-4 (Fig.27). 
The profile of cytokines upregulated upon TF-1 cells co-culturing with MS-5 
cells- IL-6, IL-4 and GM-CSF- was similar to that observed upon HA-
mediated activation of MS-5 cells. We also could not detect IL-3 or IL-1 ß 
production from MS-5 cells upon TF-1 co-culturing. 
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Figure 27. TF-1 ce/1 line stimulates the production of /L-6, GM-CSF 
and /L-4 cytokines in MS-5 cel/s. MS-5 cel/s were allowed to grow up t o 
70% confluence and were stimulated for 24 hours with 105 TF -1 ce/ls. The 
concentration of /L-6 (A), /L-4 (B) and GM-CSF (C) in supernatants was 
determined by an ELISA kits. SD was calculated from results obtained from 
triplicates. 
3.2.2 ls a direct contact between MS-5 cells and TF-1 cells required for 
cytokine production? 
MS-5 cells might be stimulated to produce cytokines by a direct cell contact 
with TF-1 cells or TF-1 cells can produce some soluble factors which are 
responsible for the TF-1- mediated cytokine response in MS-5 cells. To 
decide between these two possibilities, we performed a transweil assay. In 
this assay the two cell lines are separated by a filter. MS-5 cells were 
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cultured in 6-well culture plates up to 70 % confluence. Then the TF-1 cells 
were added to the plates either directly (for control) or seeded on transweH 
filters ( 45J.Lm). The cytokine production was measured 24 hours later. 
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Figure 28. Transweil assay. MS-5 ce/ls were grown up to 70% confluence 
and pulsed by co-culture with TF-1 cells in the presence or the absence of a 
transweil filter. The concentration of cytokine in the supernatants was monitared 
by ELISA after 24 hours. Pure TF-1 cu/ture was used as a negative control. SD 
was calculated from results obtained from triplicates.(GM-CSF kit). 
As already described the direct contact between TF-1 and MS-5 cells results 
in cytokine induction. The abrogation of the direct interaction between TF -1 
and MS-5 cells abolished the TF-1- dependent cytokine induction in MS-5 
cells (Fig.28). 
3.2.3 Effect of suramin on TF-1 stimulated cytokine production 
To test whether surface receptor contacts are required for the cytokine 
induction we tested the effect of suramin, an inhibitor of receptor activation 
(Stein, 1993), on TF-1-induced cytokine release. Pre-treatment ofMS-5 cells 
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with 3 mM of suramin prior to TF-1 addition completely abolished the TF-1 
effect (Fig.29). 
Taken together, our results suggest that the induction of cytokines in the 
stromal MS-5 cells upon TF-1 addition is dependent on a direct cell-cell 
contact via surface receptor(s). 
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Figure 29. TF-1 mediated activation of MS-5 cells can be blocked by 
suramin. MS-5 cells were grown up to 70% conf/uence. 1(/ TF-1 or H9 cel/s (as 
a control) were co-cultured with a MS-5 feeder layer with or without suramin 
pre-treatment. Cytokine concentration in the supernatants was measured by an 
ELISA kit. SD was ca/culated from resu/ts obtained from triplicates. 
3.2.4 CD44 antibodies have no influence on TF-1 triggered cytokine 
response in MS-5 cells 
CD44 was previously shown to be implicated in the processes of cell 
adhesion (for review see Simmons et al., 1997). Moreover the HA affinity 
for some progenitor cell lines was exclusively mediated by CD44 (Moll et 
al., 1998). Therefore we investigated the expression of CD44 standard and 
variant forms on the surface of TF-1 cells by FACS analysis. 5xl05 cells 
were incubated for 30 min on ice with different anti-CD44 antibodies. The 
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result of this experiment is summarised in a Tab.l. The TF-1 cells carry the 
standard and several variant epitopes of CD44 molecule. 
CD44 epitopes expressed by Anti-CD44 antibodies used for the 
TF-1 cells FACS staining. 
CD44st SFFpan 
CD44v5 VFF8 
CD44v7 VFF9 
CD44v9 VFF14 
CD44v7-8 VFF17 
CD44v6 VFF18 
Tab 1. The expression of CD44 epitopes on TF-1 cel/s. 10 5 ce/ls were 
stained with different anti-CD44 antibodies. The antibodies demonstrating 
positive staining are summarised in the table according to the CD44 epitopes 
they recognise. 
Next we tested whether a pre-treatment of cells with anti-CD44 antibodies 
had an effect on cytokine induction. Cells were pre-treated with anti-CD44 
antibodies for 30 min before co-culture. The cytokine production in the 
supematants was measured 24 hours later. Using anti-CD44 pan antibodies 
and antibodies against all expressed variant epitopes, we demonstrated that 
CD44 molecules do not play a role in TF-1 induced cytokine release in MS-5 
cells, similarly to the case ofHA-mediated activation (Fig.30). 
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Figure 30. CD44 is not involved in TF-1-mediated cytokine 
production. MS-5 ce/ls were grown up to 70% confluence. MS-5 or/and TF-1 
cells were pre-treated for 1 hour with 20 JLglml of anti-CD44 antibodies and co-
cultured for 24 hours. Afterwards, the cytokine concentration in the 
supernatants was measured by an ELISA kit. 
A) human anti-CD44 antibodies SFF-CD44st, VFFB-CD44v5, VFF9-CD44v7, 
VFF14-CD44v10, VFF17-cD44v7-8, VFF18-CD44v6. 
B) mause pan anti-CD44 antibodies /Ml (cross-react with human CD44) and 
KM81. 
SD was ca/culated from resu/ts obtained from triplicates 
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3.2.5 Support of hematopoiesis by MS-5 cells requires cytokine 
production. 
In order to compare the property of MS-5 cells to be activated to produce 
cytokines with their ability to support the survival of TF -1 cells, we 
established several MS-5 sub-lines by sub-cloning and checked these clones 
for the cytokine induction by TF -1 cells and HA. Among the sub-clones 
there were some that responded to TF -1 co-culturing but also some that did 
not respond (Fig.31). When tested for HA responsiveness, the same clones 
that were not induced for cytokine production by TF -1 also did not respond 
to HA. Moreover the inducibility of the clones positively correlated with 
their ability to support the growth ofTF-1 cells (Fig.31). 
Taken together these data indicate that the ability of the clones to be induced 
by the TF-1 cellline to produce cytokine correlates with their HA- mediated 
inducibility as weil as with their property to support the proliferation of TF-
1 cells, suggesting that in both cases a similar receptor or a similar signal 
transduction pathway might be involved. 
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Figure 31. Responsiveness of MS-5 sub-clones to HA and TF-1 
stimulation. Different sub-c/ones of MS-5 ce/1 line were grown up to 70% 
confluence and induced either with TF-1 cel/s or with HA. Cytokine concentration 
in the supernatants was measured by an ELJSA kit. (GM-CSF kit). 
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3.2.6 TF-1 cells activate the IL-6 promoter on the transcriptional Ievel 
through NF-KB and NF-IL-6 cis-elements. 
The similarities between TF-l~mediated and HA-mediated cytokine 
activation, e.g. the cytokine pattem obtained and the independence of CD44 
suggest that TF -1 activation might occur by a similar mechanism than that 
involved in HA-mediated cytokine production. We therefore tested whether 
similar sequences within the IL-6 promoter are responsible for the TF -1 
induced cytokine production by MS-5 cells. We transiently transfected the 
MS-5 cells with IL-6 promoter constructs containing truncations at the 5'. 
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Figure 32. The deletion mutants of the IL-6 promoter can abrogate 
TF-1-mediated IL-6 activation. MS-5 ce/ls were transiently transfected by 
electroporation with /L-6 promoter Juciferace reporter deletion constructs. Cel/s 
were cu/tured for 12 hours after transfection, starved tor the next 12 hours in 
medium with 0% FCS and stimulated tor 24 hours with 105 TF-1 ce/ls. After 
stimu/ation cells were Jysed and analysed for the amount of luciferase profein 
produced. The mean and SD represent three identical experiments. The figure 
represents the mean ot fold induction. 
Thereafter, MS-5 cells were plated on 5 cm2 dishes, starved and then treated 
with TF-1 cells. TF-1 cells were able to induce the IL-6 promoter activity 
(Fig.32). 
The region between -169bpto -602bp did not contribute to the TF-1 
mediated IL-6 activation, because deletion mutants covering this region did 
not show any change in inducibility by TF -1 cells as compared to the entire 
promoter (Fig32). In contrast, the deletion mutants loosing NF-IL-6 and 
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NF-KB binding sites were not inducible any more. Similarly to HA, it seems 
that the MS-5 response to the TF-1 cells regulating the production of IL-6 
depends on the activation of NF-IL-6 and NF-KB transcription factors. This 
was further confirmed by testing IL-6 promoter constructs containing point 
mutations in the NF-KB and NF-IL-6 sites. Both abrogated the response of 
MS-5 cells to TF-1 cells (Fig.33). Moreover TF-1 cells can activate a 
construct containing 3 times a repeat of an NF-KB cis-element ( 3xNF-kB 
construct), transiently transfected into MS-5 cells (Fig.34). 
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Figure 33. NF-1e8 and NF-IL-6 mutated cis- elements abrogate TF-1 
mediated activation of IL-6 promoter constructs. MS-5 cells were 
transiently transfected by electroporation with the /L-6 promoter /uciferace 
reporter constructs p/L6/uc(-602), p/L6/ucNF-1CBm, p/L6/ucNF-IL-6m. Cel/s were 
cu/tured for 12 hours after transfection, starved for the next 12 hours in 
medium with 0% FCS and stimu/ated for 24 hours by co-culture with 1 OS TF-1 
cel/s. After stimulation cells were lysed and ana/ysed for the amount of /uciferase 
profein produced. The mean and SD represent three identical experiments. 
A) Represents the mean of /uciferase relative units. 
8) Represents the mean of fold induction. 
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Figure 34. Construct containing 3xNF-KB cis-element can be 
activated in MS-5 cells by TF-1 stimulation. MS-5 cel/s were transiently 
transfected by electroporation with 3xNF-KB /uciferace reporter constructs. Cel/s 
were cu/tured 12 hours after transfection, starved for the next 12 hours in 
medium wlth 0% FCS and stimu/ated for 24 hours with TF-1 cells. After 
stimulation cel/s were /ysed and ana/ysed for the amount of luciferase protein 
produced. The mean and SD represent three identica/ experiments. 
3.2.7 Do TF-1 cells interact with MS-5 cells via HA? 
The response of MS-5 cells to TF-1 cells is by and large similar to that 
obtained with HA. Moreover, TF-1 cells can bind HA on their surface 
(Fig.35). Therefore we tested whether HA might be also involved in the TF-
1 mediated response. To remove HA from the reaction, cells were pre-treated 
with HA'ase prior to addition to the MS-5 cells. HA'ase treatment did not 
affect TF-1 mediated cytokine response (Fig.36). 
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Figure 35. TF-1 cells bind HA (FACS staining with FITC-HA). 105 ce/ls 
were stained with FITC Iabeiied HA. The fluorescence was analysed by FACS-Star 
plus flow cytometer. 
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Figure 36. The HA'ase treatment does not abrogate TF-1 mediated 
cytokine response. MS-5 cells were grown up to confluence. 1 OS TF-1 were co-
cultured on MS-5 cells with or without HA 'ase pre-treatment (HA 'ase was 
present during whole incubation time). Cytokine concentration in the 
supernatants was measured by an ELISA kit. SO was calculated from results 
obtained from trip/icates. 
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One still cannot completely exclude a role of HA in this process. Firstly, the 
components in HA 'ase preparation itself can non -specifically stimulate MS-
5 cells (data not shown). 
Secondly, MS-5 cells might be stimulated by smaller HA products which 
were not removed from the reaction. However, we believe that the TF-1 
mediated and HA mediated induction of cytokines in the MS-5 stromal cell 
line are two independent events. 
Taken together, our findings indicate that MS-5 stromal cells can be induced 
by HA to produce the cytokines IL-6, GM-CSF and IL-4. The production of 
the IL-6 cytokine is regulated by a pathway involving Raf, MEK and ERK 
molecules. This signal cascade results in the upregulation of the IL-6 
expression on the transcriptional Ievel through the NF -KB and the NF-IL-6 
cis-elements in the IL-6 promoter. 
The MS-5 cell line can also be stimulated to produce the same cytokines by 
direct contact with progenitor cells. In this case the mechanism of IL-6 
activation also involves NF-KB and NF-IL-6 elements in the IL-6 promoter. 
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4 Discussion 
Close contact with the hone marrow microenvironment is an essential 
requirement for the maturation of hematopoietic cells in adult mammals. In 
this work we concentrated on two components of the marrow environment: 
the stromal cells and the ECM component HA. We have chosen the murine 
hematopoietic supportive cell line MS-5 as an experimental system to gain 
insight into the mechanisms regulating HA-triggered cytokine production in 
stromal cells. 
At frrst we investigated the cytokine profile induced by HA in the MS-5 cell 
line. We observed the production of IL-6, GM-CSF and IL-4 upon HA 
stimulation. W e showed that despite the fact that MS-5 cells bind HA via 
CD44, the pre-treatment ofthe MS-5 cells with anti-CD44 KM81 mAbs, that 
block HA binding does not affect IL-6 nor GM-CSF production. 
HA induces a signalling cascade in MS-5 cells which results in the activation 
of the ERK and p38 MAPKs pathways as weil as in cytoskeleton 
rearrangement. Using a Raf-1 dominant-negative mutant we proved that Raf 
is an upstream target in the HA-induced signaHing cascade. 
HA induced production of IL-6 is regulated on the transcriptional Ievel, 
whereas the increase of GM-CSF is due to RNA stabilisation. NF-KB and 
NF-IL-6 cis-sequences in the IL-6 promoter are the targets ofHA action. 
The progenitor cellline TF-1 induces the production of IL-6, GM-CSF and 
IL-4 cytokines in MS-5 cells as weil. Furthermore, TF-1 cells also trigger 
IL-6 and GM-CSF responsein a CD44 independent manner. The induction 
of IL-6 by TF -1 cells is regulated on the transcriptionallevel and is mediated 
by NF-IL-6 and NF-KB cis-elements in the IL-6 promoter. 
4.1 HA-triggered cytokine activation in MS5 cells. 
The involvement of ECM components, especially HA, in hematopoiesis and 
cytokine regulationwas shown previously. HA can stimulate several cells of 
hematopoietic origin such as macrophages and dendritic cells to produce 
various cytokines (McKee et al., 1996; Hodge-Dufour et al., 1997; Haegel-
Kronenberger et al., 1998). In LTBMC the HA-triggered IL-6 production 
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seemed to be the maJor effector of hematopoiesis (Khaldoyanidi et al., 
1999). 
In MS-5 cells HA upregulates the production of IL-6, IL-4 and GM-CSF. 
HA- triggered IL-6 and GM-CSF stimulation was already described in 
BMDM and dendritic cells. The induction of IL-4 upon HA-stimulation is 
reported here for the first time. 
With respect to hematopoiesis, those cytokines have different target cells and 
act at distinct steps of the hematopoietic process. IL-6 as described before 
(see introduction) has a direct effect on primitive hematopoietic progenitor 
cell proliferation and maintenance, and synergistically interacts with other 
cytokines to stimulate the myeloid proliferation (Suda et al., 1988). In 
addition, IL-6 stimulates the granulocyte-macrophage and megakaryocyte 
colony fonnation (Lotem et al., 1989; Jansen et al., 1992). GM-CSF 
stimulates the proliferation of marrow progenitors including granulocytes, 
macrophages, erythrocytes (for review see Metcalf, 1986). It effectively 
induces granulocyte and monocyte differentiation and synergises with 
erythropoietin to support the growth of erythroid hurst fonning units (Sieff 
et al., 1985). Later on, GM-CSF enhances the functions of mature effector 
cells (Handman and Burges, 1979; Weisbart et al., 1986; Grabstein et al., 
1986; Weiser et al., 1987). IL-4 has a more restricted effect in the 
hematopoietic system and was described to act predominantly in 
lymphopoiesis. It stimulates B-eeil maturation and immunoglobulin 
production; generates cytotoxic and helper T-lymphocytes (Howard et al., 
1982; Vitetta et al., 1984; Noma et al., 1986; Coffman et al., 1986). By 
interacting with other growth factors it takes part in the regulation of 
megakaryocyte, granulocyte-macrophage and mast cell proliferation in 
murine system (Peschel et al., 1987; Broxmeyer and Cooper, 1988). Taken 
tagether these data indicate that the induction of those three cytokines by the 
same population of hone marrow stromal cells might be required to support 
different sub-populations of progenitor cells. 
The cytokines induced by HA in MS-5 cells are in partdifferent from those 
induced in BMDM, where IL-1ß and IL-6 were upregulated upon HA-
treatment. A plausible explanation for this fact could be that this difference 
reflects a divergent action of HA on various stromal cell compartments. Most 
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importantly, the IL-6 cytokine, which was shown to be the crucial 
component induced in L TBMC, was also produced in MS-5 cells upon HA 
stimulation. However, the L TBMC cultures mirnie some (particularly early) 
but not all steps of hematopoiesis. Therefore, production of two other 
cytokines (particularly GM-CSF) can also be physiologically relevant for 
other (or later) steps in hematopoiesis or for certain sub-populations of 
hematopoietic progenitors which are not present in LTBMC. 
4.1.1 Putative receptor for the HA effect in MS5 cells. 
The HA effect on the MS-5 cells could be mediated in two different ways: 
HA can be uptaken via endocytosis or may act through cell surface HA-
receptors. W e believe that in our system an interaction with a receptor is 
most likely involved. lndeed, MS-5 cells could be induced by immobilised 
HA from HA-covered plates as weil as by soluble HA. Unfortunately, we 
could not support this observation by using endocytosis inhibitors, since they 
dramatically affected the morphology and survival of MS-5 cells, therefore 
we cannot completely exclude the possibility of an endocytotic process. 
The possible involvement of a receptor -Iigand interaction raiseS:he question 
about the relevant HA-receptor responsible for the effect. One candidate 
could be the CD44 adhesion molecule. CD44 is known to be the principle 
receptor for HA and has been shown to be involved in the regulation of 
hematopoiesis (Aruffo et al., 1990; Moll et al., 1998). Moreover, HA 
binding to CD44 was reported to induce IGF-1, IL-1ß, MIP-1a, MIP-1ß and 
TNF-a cytokines in BMDM (Noble et al., 1993; McKee et al., 1996). 
Recently, HA-induced IL-6 production by dendritic cells was reported tobe 
CD44 mediated (Haegel-Kronenberger et al., 1998). Although the HA 
binding by MS-5 cells could be by and large repressed by anti-CD44 KM81 
mAbs, the same mAbs did not abrogate IL-6 increase nor the GM -CSF 
production suggesting the action of HA via a different receptor. This 
observation is in agreement with previous findings in BMDM, in which IL-6 
production was also induced in a CD44 independent manner (Khaldoyanidi et 
al., 1999). 
There are several evidences that other unknown HA-receptors are existing. 
Moreover, HA effects can be mediatedvia such HA-binding receptors, even 
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when CD44 is also present on the cell surface. For example it was shown that 
brain endothelial cells carry an unknown HA-binding receptor in addition to 
CD44 (Rahmanian et a/., 1997). The stimulating effect of HA on BMDM is 
provided by CD44 and another unidentified receptor (Khaldoyanidi et al., 
1999). HA-mediated ehemoleine induction in alveolar macrophages, 
described by McKee et al, is only in part mediated by CD44 and the 
existence of additional unknown receptor was postulated by the authors 
(McKee et a/., 1996). 
The possible presence of an HA binding protein, other than CD44, on MS-5 
cells is supported by CPC precipitation experiments, where several proteins 
can be shown to interact with HA. Taken together, we propose that MS-5 
cells carry in addition to CD44 another (or others) HA-binding receptor(s) 
which might be responsible for the HA-mediated cytokine upregulation. 
4.1.2 HA-induced signalling cascade 
The interaction between HA and cell surface receptors has been shown to 
generate a variety of signaHing events including triggering of tyrosine kinase 
activation, transient increase of tyrosine phosphorylation of some proteins, 
and focal adhesion turnover (for review see Entwistle et a/., 1996). In MS-5 
cells we observed activation of p38 and ERK MAPKs upon HA Stimulation. 
In BMDMs, HA also induced activation of ERK and p38. However, in 
BMDM the p38 activation was involved in the induction of IL-1 ß. In our 
system p38 activation did not result in IL-1 ß upregulation. One could 
speculate that the signalling cascade induced by HA is similar between 
different stromal cells. However, it might Iead to the regulation of divergent 
target genes underlining additionally the divergence between stromal cell 
populations. 
In addition to MAPK activation we observed cytoskeleton rearrangement in 
MS-5 cells upon HA treatment leading to lamellopodia- like filament 
structures and ruffles. The signalling pathways that induce different 
cytoskeleton pattems converge at one or several members of the Rho family 
of small GTP-binding proteins (Cdc 42, Rac and Rho) (Zigmond, 1996). As 
it was described in a fibroblast model, constitutively active Cdc42 induces 
lamellopodias, activation of Rac Ieads to the membrane ruffles, and 
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activation of Rho induces stress fibers (Nobes and Hall, 1995). Therefore the 
induction of lamellopodias and ruffies in MS-5 cells upon HA treatment 
would speak for an activation of Cdc 42 and Rac GTP-binding proteins. 
4.1.3 HA-induced signal regulates IL-6 production on the 
transcriptionallevel 
We found that in MS-5 stromal cells the IL-6 production is regulated on 
transcriptionallevel, whereas the GM-CSF response seems to be controlled 
by posttranscriptional events. This is in line with the fact that the regulation 
of IL-6 gene in most systems occurs at the transcriptional Ievel although 
mechanisms of post-transcriptional regulation have also been described 
(Akira and Kishimoto, 1997). For example activation of IL-6 by IFN-y and 
TNF -a is transcriptionally controlled. Induction of IL-6 by hypoxia, by 
human hepatitis B virus, LPS and a variety of other agents as well as 
repression by the estrogen receptor or estradiol is also regulated at the 
transcriptional Ievel (Ray et al., 1995; Matsiu et al., 1999; Ohno et al., 
1999). GM-CSF can be regulated m both transcriptional and 
postranscriptional manner depending from the inducing event as it has been 
described for hone marrow stromal cells (Derigs et al., 1994). Interestingly, 
in MS-5 cells the same stimulus (HA) contro1s the production of GM-CSF 
and IL-6 on different Ievels. 
The observation that IL-6 is induced by HA on the transcriptional Ievel 
means that the interaction between certain transcription factors and 
corresponding DNA cis-elements is responsible for this phenomena. Several 
cis-elements controlling IL-6 expression were previously described in the IL-
6 promoter. We report here that NF-KB and NF-IL-6 cis-elements are crucial 
for the HA-mediated IL-6 response. Our finding that NF-KB is involved in 
HA response is in agreement with the case of the INOX gene induced by HA 
in monocytes, where NF-KB activation is also needed (McKee et al., 1997). 
To our knowledge, we report here for the firsttime the involvement of NF-
IL-6 in a response to a component of the ECM. 
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4.1.4 NF-KB and NF-IL-6 factors are the targets for HA-signalling 
4.1.4.1 NF-KB 
NF-KB exists in the cytoplasm of a majority of cell types as homo- or hetero-
dimers of a family of structurally related proteins (Rel-family). In its 
inactive form NF-KB is associated with the inhibitory protein (IKB) and can 
be activated in cells by a wide variety of stimuli through the signal-induced 
proteolytic degradation of IKB in the cytoplasm (Fig.37). 
Rac 
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Extracellular signals 
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Intermediate 
kinases 
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Figure 37. Signalling cascades /eading to the activation of NF-1CB. 
IKKa/IKKß: I1CB Kinase; MEKK1: Mitogen- activated protein kinase/ extracellular 
signal-regulated kinase kinase-1; NIK: NF-1CB inducing kinase; p90-RSK: p90-
ribosomal s6 protein kinase; P: phosphate; PKAc: Protein kinase A catalytic 
subunit; PKC: protein kinase C. 
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With regard to the HA-mediated IL-6 production, we have been able to show 
two important points. Firstly, the removal of NF-KB cis-element from the 
IL-6 promoter completely abolishes HA-induced IL-6 response. Secondly, 
the inhibition of the Raf- Mek -Erk pathway abrogates HA-mediated IL-6 
production. These findings suggest a putative connection between the ERK 
cascade and the NF-KB activation in our model. 
Several observations from other systems support our findings. E.g. in 
lymphoblastoid cells overexpression of either MEK1 or ERK results in 
constitutive nuclear localisation ofNF-KB (Briant et a/., 1998). In COS cells 
the downstream kinase of Raf-MEK-ERK. pathway -90 RSKl- has been 
observed to phosphorylate the N-terminal regulatory domain of IKB and thus 
to enhance NF-KB DNA-binding (Ghoda et a/., 1997). Okadaik acid-
stimulated IL-6 production in human monocytes includes the activation of 
Raf-MEK-ERK cascade resulting in enhancing of the transactivation capacity 
of NF-lCB {Tuyt et a/., 1999). In addition, okadaic acid-activated ERK was 
reported to phosphorylate GST-IKB in vitro (Sonoda et al., 1997). 
These findings suggest the involvement of the classical ERK pathway in the 
inactivation of I KB. Our observations provide additional evidence that the 
ERK. pathway might be a signaHing pathway regulating the NF-KB activity, 
however the mechanism of this activation is still unclear. 
The p38 activation was also shown to result in NF-KB activation in some 
systems (reviewed by Schulze-Osthoff et a/., 1997; Vanden Berghe et al., 
1998). Although we did not test the direct involvement of p38 signaHing 
pathway in HA-triggered NF-KB activation in our system, we believe that 
p38 activation is not relevant in this respect. The basis for this assumption is 
that a specific p38 inhibitor does not affect HA-induced IL-6 response. 
4.1.4.2 NF-IL-6 
The NF-IL-6 transcription factor, also named CEBP/ß, is a member of the 
CCAAT/enhancer-binding proteins (CEBP) family. This factor modulates 
expression of multiple genes important in host adaptive-, immune- and 
hematopoietic processes. 
NF-IL-6 is responsible for the activation ofiL-6 by several stimuli including 
IL-1, IL-4, bacterial and viral infections (Nakazato et a/., 1998; Zhu et al., 
95 
Discussion --------------------------------------------~ 
1996; Zhang et al., 1995). We show in this work involvement of NF-IL-6 in 
HA-triggered IL6- response. 
NF-IL-6 activity is regulated by phosphorylation and can be achieved by 
different mechanisms. Of particular interest is the finding that the Ras-Raf-
MEK-ERK. pathway Ieads to phosphorylation and activation of NF-IL-6 
(Popik et al., '1998; Reddy et al., 2000). This is in accordance with our 
assurnption that the HA signal leading to NF-IL-6 activation might include 
and require stimulation ofthe Raf-MEK-ERK cascade. 
4.1.4.3 NF-lCB and NF-IL-6 synergise in HA-induced IL-6 induction 
In our experimental system NF-IL-6 factor seems to synergise with NF-lCB. 
A nurober of different transcription factors have been reported to be able 
physically and functionally to interact with C/EBP members and in particular 
with NF-IL-6. The interactions with members of NF-lCB family of 
transcription factors play a crucial role in the regulation of expression of 
various cytokine genes (Y amanaka et al., 1998; Akira and K.ishimoto, 1997). 
Synergistic activation by NF-IL-6 and NF-KB has been also shown for the 
regulation of the genes encoding the acute phase response (Matsusaka et al., 
1993). The induction of IL-6 by hypoxia was also shown tobe mediated by 
NF-KB and NF-IL-6 factors in monocytes (Matsui et al., 1999). Synergism 
between NF-lCB and NF-IL-6 factors is also responsible for IL-6 regulation 
by estrogenes (Stein et al., 1995). 
In our experiments, skipping or mutating the NF-KB cis-element resulted in 
complete abrogation of HA-induced IL-6 production, whereas skipping or 
inactivation of the NF-IL-6 element showed some residual HA-mediated IL-
6 response. A similar effect was observed in hypoxia regulated IL-6 
expression (Matsui et al., 1999). One could assume that NF-lCB cis-element 
suffice for the initial induction, but the promoter activation needs a 
subsequent ~ccumulation of a certain amount of transcription factors. 
We speculate that since the induction of NF-IL-6 usually occurs relatively 
late after stimulation, it is likely that the transcription factor NF-lCB whose 
activation is normally much faster but transient is responsible for the 
initiating of induction of IL-6, being accompanied later on by NF-IL-6 
members. 
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4.2 TFl- MS-5 cross-talk 
4.2.1 MS-5 cellline supports tbe growth of TF-1 cells 
MS-5 ceHs support survival and proliferation of the progenitor ceH line TF-
1. During the preparation of this work a paper was published which also 
reports the support of TF-1 ceHs by the MS-5 ceH line (Heberlein et al., 
1999). The authors implied that the Stern ceH factor (SCF) produced by MS5 
cells is responsible for this supportive effect. The cytokine GM-CSF was not 
considered as a supportive factor by these authors. We, as weH as other 
groups (Suzuki et al., 1992), showed that MS-5 ceHs produce a basic level of 
GM-CSF and IL-6 and the amount of GM-CSF and IL-6 is significantly 
upregulated upon TF-1 co-culture. In additionmousepure recombinant GM-
CSF also supports the proliferation of TF-1 ceHs. Moreover, it was found 
that IL-6 as weH support the growth of TF-1 cells (Kitamura et al., 1991). 
Taken together, these data suggest that in addition to SCF, GM-CSF and IL-
6 might be responsible for the MS-5 effect on TF-1 cells. 
4.2.2 Progenitor- mediated cytokine induction in stromal cell 
The cytokines induced by TF-1 cells in MS-5 cells are the same as those 
induced by HA treatment. Furthermore, TF -1 cells regulate IL-6 production 
in MS-5 cells at the transcriptional level through NF-lCB and NF-IL-6 cis-
elements similar to HA. Multiple myeloma cells can also trigger NF-KB 
activation and IL-6 production in stromal cells (Chauhan et al., 1996). 
Contact between thymocytes and thymic epithelial cells (TEC) activates NF-
IL-6 and NF-KB transcription factors as well as IL-6 production in human 
TECs (Ramarli et al., 1998). These Observations argue for the general 
relevance of this cytokine induction in stromal cells by progenitor ceHs in the 
hematopoietic system. Therefore, we can assume that this cytokine induction 
is rather a more common feature of progenitors than just a unique ability of 
TF-1 cells. 
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4.2.3 How does TF-1 activate MS-5 cells? 
Two possibilities can be proposed for TF-1 action on stromal cells. They can 
either stimulate stromal cells via cell- cell contact or upon production of a 
soluble MS-5 activating factor. Recently the upregulation of IL-6 and G-CSF 
in human hone marrow stromal cell layers upon co-culture with CD34+ hone 
marrow cells in LTBMC was reported (Gupta et al., 1998b). In this report 
the authors postulated the production of a soluble factor by progenitor cells, 
since direct contact between cells appeared not to be essential in that system. 
In our experimental system the contact between progenitors and stromal cells 
is required for the upregulation of cytokine production, since the separation 
of cells by a transweH membrane or pre-treatment of cells with suramin 
could abolish the TF-1 mediated cytokine response. 
We did not clarify yet which receptor could be responsible for the TF -1 
induced cytokine production in MS-5 cells, although we showed that this 
effect is independent from CD44 adhesion receptor. Most likely candidates 
are integrins, which are weil known to play a role in cell -cell adhesion and 
cytoskeleton rearrangement (Clark et al., 1998; Defilippi et al., 1999). lt has 
been already shown that integrins play a role in adhesion of progenitor cells 
to the stromal cells (Simmons et al., 1992). Furthermore, several reports 
implicated integrin family members in cytokine induction (Yurochko et al., 
1992; Jarvis et al., 1995; Lee et al., 1999). Moreover, there are Observations 
connecting integrin-induced signals to NF-KB activation (Udagwa et al., 
1996; Rasalesand Juliano, 1996; Scatena et al., 1998). Lastly, monoclonal 
antibody-mediated dustering of a3ß1 or a6ß4 integrins have been shown to 
mirnie thymocyte contact and to activate interleukin-6 production in human 
thymic epithelial cells by the same mechanism as the one used by thymocytes 
(Ramarli et al., 1998). 
The similarity between HA and TF-1 mediated MS-5 activation triggers the 
question whether TF-1 cells might act on MS-5 cells via HA. Since the 
treatment of TF-1 and MS-5 cells with hyaluronidase could not affect TF-1 
mediated cytokine response, we assume that despite some similarities, TF -1 
and HA action on stromal cells might represent two independent 
mechanisms. This conclusion is in line with experiments in thymocyte or 
multiple myeloma models where no intermediate ECM components were 
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shown to be involved in cytokine production in stromal cells upon cell-cell 
interactions (Chauhan et al., 1996; Ramarli et al., 1998). 
In conclusions, this work explored the mechanism of regulated cytokine 
production by stromal cells. We were able to show several important points: 
1. HA and TF-1 cells activate cytokine production in the stromal MS-5 cells. 
2. IL-6 is transcriptionally upregulated. 
3. The signal cascade to IL-6 gene activation involves the RAF-MEK- ERK 
pathway. 
4. HA and CD34+TF-1 progenitors regulate IL-6 expressionvia NF-kB and 
NF-IL-6 DNA- cis-elements. 
5. Despite some similarities, the HA-induced and TF-1 induced cytokine 
production seem to present two independent mechanisms. 
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Abbreviations 
A 
ACTD 
AGM 
APS 
ATP 
BMDM 
BMP 
bp 
Bq 
BSA 
CAM 
CD 
cDNA 
Ci 
cm 
CPC 
cpm 
es 
CSF 
DEPC 
DMEM 
DMSO 
DNA 
dNTP 
Dom-neg 
DTT 
EB 
ECL 
ECM 
Eds 
EDTA 
ELISA 
ERK 
ES cell 
etal 
FACS 
FCS 
FITC 
Ampere 
Actinomycin D 
Aorta- Gonad-Mesonephros 
Ammoniumpersulfate 
Adenosine Triphosphate 
Bone Marrow Derived Macraphages 
Bone Morphogenie Protein 
Base pair 
Bequerel 
Bovine Serum Albumin 
Cell Adhesion Moleeule 
Cluster of Differentiation 
Complementary DNA 
Curi 
Centimeter 
Cetylpyridinium chloride 
Counts per minute 
Chondroitin sulfate 
Colony Stimulating Factor 
Diethylpyrocarbonate 
Dulbecco s Modified Eagle Medium 
Dimethylsulfoxide 
Deoxyribonucleic Acid 
Deoxyribonucleoside triphosphate 
Dominant negative 
Dithiotreitol 
Embryonie Body 
Enhanced chemiluminescence 
Extracellular Matrix 
Editors 
Ethylendiamine-N ,N -tetracetate 
Enzyme- linked immunosorbent assay 
Extracellular signal regulated kinase 
Embryonie Stern Cell 
and others (Lat. et alii) 
Fluorescence- Activated Cell Sorter 
Fetal Calf Serum 
Fluorescein Isothiocianate 
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g 
GAG 
G-CSF 
GFP 
GM-CSF 
h 
HA 
HE PES 
HPLC 
HRP 
HSC 
HSP 
ICAM 
IFN 
Ig 
IGF 
IL 
INOS 
K 
Kb 
kDa 
L 
LIF 
LPS 
LTBMC 
Luc 
m 
Jl 
M 
MAb 
MAPK 
M-CSF 
:rmn 
MIP 
MME 
MMP 
MOPS 
mRNA 
MW 
n 
NF-IL-6 
NF-lCB 
Gram 
Glycosaminoglycan 
Granulocyte- Colony Stimulating Factor 
Green Fluorescence Protein 
Granulocyte-Macrophage Colony Stimulating Factor 
Ho ur 
Hyaluronic acid 
N-2-Hydroxyethylpiperrasine-N'-2-ethansulfonic acid 
High Pressure Liquid Chromatography 
Horseradish peroxidase 
Hematopoietic Stern Cell 
Heparan sulfated proteoglycan 
Intercellular Adhesion Moleeule 
Interferon 
Immunoglobulin 
Insulin-like Growth Factor 
Interleukin 
Inducible nitric oxide synthase 
Kilo (103) 
Kilobase (lkb=l OOObp) 
Kilodalton (lkd=lOOOdaltons) 
Litre 
Leukemia Inhibitory Factor 
Lipopolysaccharide 
Long Tenn Bone Marrow Culture 
Luciferase 
Milli (1 o-3) 
Micro(l 0-6) 
Molar 
Monoclonal antibody 
Mitogen- activated protein kinase 
Macrophage- Colony Stimulating Factor 
Minute 
Macraphage Inflammatory Protein 
Matrixmetalloelastase 
Matrixmetalloproteinases 
4-morpholinepropanesulfonic acid 
Messenger RNA 
Molecular weight 
Nano (10-9) 
Nuclear factor IL-6 
Nuclear factor-Kß 
102 
--------------------~ bbreviations 
NP-40 
0/N 
oc 
OD 
p 
PAGE 
PAS 
PBS 
PCR 
PDGF 
PE 
PI3K 
PMSF 
R 
Rel 
RNA 
rpm 
RT 
RT-PCR 
SCF 
SD 
SDS 
sec 
st 
TEC 
TEMED 
TGF 
TNF 
TPA 
Tris 
tRNA 
u 
uv 
V 
V 
v/v 
VCAM 
VEGF 
VLA 
vol 
w 
w/v 
wt 
Nonidet P40 
Ovemight 
Degree Celsius 
Optical density 
Pico(l o-12} 
Polyacrilamide gel electrophoresis 
Paraaortic-Splanchnopleura 
Phosphate buffered saline 
Polymerase Chain Reaction 
Platelet Derived Growth Factor 
Phycoerythrin 
Phosphatidyl-lnositol-3 Kinase 
Phenylmethylsulfonyl fluoride 
Recombinant 
Relative 
Ribonucleic Acid 
Revolutions per minute 
Room Temperature 
Reverse transcription PCR 
Stern Cell Factor 
Standard deviation 
Sodium dodecil sulfate 
Secotid 
Standard 
Thymic Epithelial Cell 
N ,N ,N' ,N!tetramethyl-ethylendiamin 
Transforming Growth Factor 
Tun10ur Necrosis Factor 
12-0-tetradecanoylphorbol-13-acetate 
Tris-(hydroxymethyl)- aminometharr 
transfer RNA 
Unit 
Ultravialet 
Variant 
Volt 
Volume per volume 
V ascular Cell Adhesion Moleeule 
V ascular Endothelial Growth Factor 
Very Late Antigen 
Volume 
Watt 
Weight per volume 
Wild type 
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